Frequencies for first 10,000 rows of pt variable in reac2010q4 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- 5Q MINUS SYNDROME | 1 0.01 0.01 ABASIA | 12 0.12 0.13 ABDOMINAL ABSCESS | 1 0.01 0.14 ABDOMINAL ADHESIONS | 1 0.01 0.15 ABDOMINAL DISCOMFORT | 16 0.16 0.31 ABDOMINAL DISTENSION | 14 0.14 0.45 ABDOMINAL HERNIA | 1 0.01 0.46 ABDOMINAL HERNIA OBSTRUCTIVE | 1 0.01 0.47 ABDOMINAL NEOPLASM | 1 0.01 0.48 ABDOMINAL PAIN | 53 0.53 1.01 ABDOMINAL PAIN LOWER | 2 0.02 1.03 ABDOMINAL PAIN UPPER | 38 0.38 1.41 ABDOMINAL TENDERNESS | 1 0.01 1.42 ABDOMINAL WALL ABSCESS | 1 0.01 1.43 ABNORMAL BEHAVIOUR | 7 0.07 1.50 ABNORMAL DREAMS | 9 0.09 1.59 ABNORMAL FAECES | 4 0.04 1.63 ABNORMAL SENSATION IN EYE | 1 0.01 1.64 ABORTION | 1 0.01 1.65 ABORTION INDUCED | 1 0.01 1.66 ABORTION SPONTANEOUS | 15 0.15 1.81 ABSCESS | 4 0.04 1.85 ABSCESS DRAINAGE | 3 0.03 1.88 ABSCESS LIMB | 1 0.01 1.89 ABSCESS MANAGEMENT | 1 0.01 1.90 ABSCESS ORAL | 1 0.01 1.91 ACCIDENT | 1 0.01 1.92 ACCIDENTAL DRUG INTAKE BY CHILD | 1 0.01 1.93 ACCIDENTAL EXPOSURE | 4 0.04 1.97 ACCIDENTAL OVERDOSE | 4 0.04 2.01 ACETABULUM FRACTURE | 1 0.01 2.02 ACIDOSIS | 1 0.01 2.03 ACNE | 4 0.04 2.07 ACNE CYSTIC | 1 0.01 2.08 ACNE INFANTILE | 1 0.01 2.09 ACTINOMYCOTIC PULMONARY INFECTION | 1 0.01 2.10 ACTIVITIES OF DAILY LIVING IMPAIRED | 6 0.06 2.16 ACUTE ABDOMEN | 2 0.02 2.18 ACUTE CORONARY SYNDROME | 2 0.02 2.20 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS | 1 0.01 2.21 ACUTE GRAFT VERSUS HOST DISEASE IN IN.. | 3 0.03 2.24 ACUTE GRAFT VERSUS HOST DISEASE IN LI.. | 1 0.01 2.25 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN | 1 0.01 2.26 ACUTE HEPATIC FAILURE | 3 0.03 2.29 ACUTE MYELOID LEUKAEMIA | 4 0.04 2.33 ACUTE MYOCARDIAL INFARCTION | 9 0.09 2.42 ACUTE PSYCHOSIS | 1 0.01 2.43 ACUTE PULMONARY OEDEMA | 3 0.03 2.46 ACUTE RESPIRATORY DISTRESS SYNDROME | 3 0.03 2.49 ACUTE RESPIRATORY FAILURE | 4 0.04 2.53 ADAMS-STOKES SYNDROME | 1 0.01 2.54 ADDISON'S DISEASE | 1 0.01 2.55 ADMINISTRATION RELATED REACTION | 1 0.01 2.56 ADMINISTRATION SITE PAIN | 1 0.01 2.57 ADRENAL ADENOMA | 1 0.01 2.58 ADRENAL INSUFFICIENCY | 3 0.03 2.61 ADRENOCORTICAL INSUFFICIENCY ACUTE | 1 0.01 2.62 ADVERSE DRUG REACTION | 7 0.07 2.69 ADVERSE EVENT | 5 0.05 2.74 AFFECT LABILITY | 1 0.01 2.75 AFFECTIVE DISORDER | 1 0.01 2.76 AGEUSIA | 2 0.02 2.78 AGGRESSION | 11 0.11 2.89 AGITATION | 16 0.16 3.05 AGRANULOCYTOSIS | 3 0.03 3.08 AGRAPHIA | 2 0.02 3.10 AIDS ENCEPHALOPATHY | 1 0.01 3.11 AKATHISIA | 1 0.01 3.12 ALANINE AMINOTRANSFERASE INCREASED | 10 0.10 3.22 ALBUMINURIA | 1 0.01 3.23 ALLERGIC GRANULOMATOUS ANGIITIS | 1 0.01 3.24 ALLERGIC SINUSITIS | 1 0.01 3.25 ALLERGY TO METALS | 1 0.01 3.26 ALOPECIA | 23 0.23 3.49 ALPHA 1 FOETOPROTEIN INCREASED | 1 0.01 3.50 ALTERED STATE OF CONSCIOUSNESS | 7 0.07 3.57 ALTERED VISUAL DEPTH PERCEPTION | 1 0.01 3.58 ALVEOLITIS ALLERGIC | 6 0.06 3.64 AMAUROSIS FUGAX | 1 0.01 3.65 AMENORRHOEA | 7 0.07 3.72 AMINOACIDURIA | 1 0.01 3.73 AMMONIA INCREASED | 1 0.01 3.74 AMNESIA | 22 0.22 3.96 AMYLOIDOSIS | 1 0.01 3.97 ANAEMIA | 52 0.52 4.49 ANAEMIA HAEMOLYTIC AUTOIMMUNE | 3 0.03 4.52 ANAEMIA MACROCYTIC | 2 0.02 4.54 ANAL ABSCESS | 4 0.04 4.58 ANAL FISSURE | 1 0.01 4.59 ANAL FISTULA | 2 0.02 4.61 ANAL ULCER | 1 0.01 4.62 ANAPHYLACTIC REACTION | 4 0.04 4.66 ANAPHYLACTIC SHOCK | 3 0.03 4.69 ANEURYSM | 2 0.02 4.71 ANGER | 11 0.11 4.82 ANGINA PECTORIS | 4 0.04 4.86 ANGINA UNSTABLE | 2 0.02 4.88 ANGIODYSPLASIA | 1 0.01 4.89 ANGIOEDEMA | 5 0.05 4.94 ANGIOLIPOMA | 1 0.01 4.95 ANGIOPATHY | 4 0.04 4.99 ANGIOPLASTY | 1 0.01 5.00 ANHEDONIA | 15 0.15 5.15 ANHIDROSIS | 1 0.01 5.16 ANIMAL BITE | 1 0.01 5.17 ANKLE FRACTURE | 6 0.06 5.23 ANKYLOSING SPONDYLITIS | 2 0.02 5.25 ANOGENITAL WARTS | 1 0.01 5.26 ANORECTAL DISCOMFORT | 2 0.02 5.28 ANORECTAL OPERATION | 1 0.01 5.29 ANORGASMIA | 2 0.02 5.31 ANOSMIA | 1 0.01 5.32 ANTI-ERYTHROPOIETIN ANTIBODY | 1 0.01 5.33 ANTI-HBS ANTIBODY POSITIVE | 1 0.01 5.34 ANTIBODY TEST POSITIVE | 1 0.01 5.35 ANTICONVULSANT DRUG LEVEL DECREASED | 2 0.02 5.37 ANTICONVULSANT DRUG LEVEL INCREASED | 1 0.01 5.38 ANTIPHOSPHOLIPID SYNDROME | 1 0.01 5.39 ANTIPSYCHOTIC DRUG LEVEL INCREASED | 3 0.03 5.42 ANURIA | 4 0.04 5.46 ANXIETY | 72 0.72 6.18 ANXIETY DISORDER | 1 0.01 6.19 AORTIC ANEURYSM | 2 0.02 6.21 AORTIC ARTERIOSCLEROSIS | 1 0.01 6.22 AORTIC CALCIFICATION | 1 0.01 6.23 AORTIC DISORDER | 2 0.02 6.25 AORTIC STENOSIS | 2 0.02 6.27 AORTIC THROMBOSIS | 1 0.01 6.28 AORTIC VALVE INCOMPETENCE | 3 0.03 6.31 APATHY | 4 0.04 6.35 APGAR SCORE LOW | 1 0.01 6.36 APHAGIA | 1 0.01 6.37 APHASIA | 10 0.10 6.47 APHONIA | 2 0.02 6.49 APLASIA PURE RED CELL | 1 0.01 6.50 APNOEA | 1 0.01 6.51 APPARENT DEATH | 1 0.01 6.52 APPENDICECTOMY | 1 0.01 6.53 APPENDIX DISORDER | 1 0.01 6.54 APPLICATION SITE BURN | 4 0.04 6.58 APPLICATION SITE DISCOMFORT | 1 0.01 6.59 APPLICATION SITE EROSION | 1 0.01 6.60 APPLICATION SITE ERYTHEMA | 2 0.02 6.62 APPLICATION SITE EXFOLIATION | 1 0.01 6.63 APPLICATION SITE PAIN | 2 0.02 6.65 APPLICATION SITE PRURITUS | 1 0.01 6.66 APPLICATION SITE RASH | 3 0.03 6.69 APPLICATION SITE REACTION | 2 0.02 6.71 APPLICATION SITE SCAB | 1 0.01 6.72 APPLICATION SITE SCAR | 2 0.02 6.74 APPLICATION SITE VESICLES | 2 0.02 6.76 ARM AMPUTATION | 1 0.01 6.77 ARNOLD-CHIARI MALFORMATION | 1 0.01 6.78 ARRHYTHMIA | 7 0.07 6.85 ARTERIAL DISORDER | 3 0.03 6.88 ARTERIAL HAEMORRHAGE | 1 0.01 6.89 ARTERIAL INJURY | 1 0.01 6.90 ARTERIAL OCCLUSIVE DISEASE | 4 0.04 6.94 ARTERIAL STENT INSERTION | 2 0.02 6.96 ARTERIAL THROMBOSIS | 1 0.01 6.97 ARTERIOSCLEROSIS | 6 0.06 7.03 ARTERIOSCLEROSIS CORONARY ARTERY | 3 0.03 7.06 ARTERIOVENOUS MALFORMATION | 1 0.01 7.07 ARTERITIS | 1 0.01 7.08 ARTHRALGIA | 62 0.62 7.70 ARTHRITIS | 17 0.17 7.87 ARTHRITIS BACTERIAL | 4 0.04 7.91 ARTHROPATHY | 14 0.14 8.05 ARTHROPOD BITE | 2 0.02 8.07 ARTHROPOD STING | 1 0.01 8.08 ARTIFICIAL CROWN PROCEDURE | 1 0.01 8.09 ASCITES | 3 0.03 8.12 ASPARTATE AMINOTRANSFERASE INCREASED | 8 0.08 8.20 ASPHYXIA | 1 0.01 8.21 ASPIRATION | 2 0.02 8.23 ASPIRATION PLEURAL CAVITY | 1 0.01 8.24 ASTERIXIS | 1 0.01 8.25 ASTHENIA | 84 0.84 9.09 ASTHENOPIA | 1 0.01 9.10 ASTHMA | 17 0.17 9.27 ASTIGMATISM | 1 0.01 9.28 ATAXIA | 2 0.02 9.30 ATELECTASIS | 9 0.09 9.39 ATRIAL FIBRILLATION | 16 0.16 9.55 ATRIOVENTRICULAR BLOCK | 2 0.02 9.57 ATRIOVENTRICULAR BLOCK COMPLETE | 3 0.03 9.60 ATRIOVENTRICULAR BLOCK FIRST DEGREE | 4 0.04 9.64 ATRIOVENTRICULAR BLOCK SECOND DEGREE | 1 0.01 9.65 ATROPHY | 2 0.02 9.67 AUTOIMMUNE NEUROPATHY | 1 0.01 9.68 AUTONOMIC FAILURE SYNDROME | 1 0.01 9.69 AXILLARY PAIN | 1 0.01 9.70 AZOTAEMIA | 2 0.02 9.72 B-CELL LYMPHOMA | 1 0.01 9.73 BACK DISORDER | 3 0.03 9.76 BACK INJURY | 1 0.01 9.77 BACK PAIN | 38 0.38 10.15 BACTERAEMIA | 1 0.01 10.16 BACTERIAL DISEASE CARRIER | 1 0.01 10.17 BACTERIAL INFECTION | 5 0.05 10.22 BACTERIAL SEPSIS | 2 0.02 10.24 BALANCE DISORDER | 30 0.30 10.54 BARRETT'S OESOPHAGUS | 1 0.01 10.55 BASAL CELL CARCINOMA | 4 0.04 10.59 BEDRIDDEN | 1 0.01 10.60 BENIGN BREAST NEOPLASM | 2 0.02 10.62 BENIGN NEOPLASM OF BLADDER | 1 0.01 10.63 BENIGN NEOPLASM OF SKIN | 1 0.01 10.64 BENIGN OVARIAN TUMOUR | 2 0.02 10.66 BENIGN PROSTATIC HYPERPLASIA | 1 0.01 10.67 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION | 1 0.01 10.68 BILE DUCT CANCER | 1 0.01 10.69 BILE DUCT OBSTRUCTION | 1 0.01 10.70 BILE DUCT STONE | 2 0.02 10.72 BILIARY COLIC | 1 0.01 10.73 BILIARY DYSKINESIA | 8 0.08 10.81 BIOPSY GINGIVAL | 1 0.01 10.82 BIPOLAR DISORDER | 6 0.06 10.88 BLADDER CANCER | 2 0.02 10.90 BLADDER CANCER STAGE 0, WITH CANCER I.. | 1 0.01 10.91 BLADDER CATHETERISATION | 1 0.01 10.92 BLADDER DILATATION | 2 0.02 10.94 BLADDER DISORDER | 6 0.06 11.00 BLADDER DYSFUNCTION | 1 0.01 11.01 BLADDER PROLAPSE | 1 0.01 11.02 BLADDER SPASM | 1 0.01 11.03 BLAST CELL COUNT INCREASED | 1 0.01 11.04 BLAST CELLS PRESENT | 1 0.01 11.05 BLEPHARITIS | 2 0.02 11.07 BLINDNESS | 24 0.24 11.31 BLINDNESS UNILATERAL | 2 0.02 11.33 BLISTER | 4 0.04 11.37 BLOOD ALBUMIN DECREASED | 1 0.01 11.38 BLOOD ALKALINE PHOSPHATASE INCREASED | 5 0.05 11.43 BLOOD AMYLASE INCREASED | 5 0.05 11.48 BLOOD BILIRUBIN INCREASED | 4 0.04 11.52 BLOOD CALCIUM ABNORMAL | 1 0.01 11.53 BLOOD CALCIUM DECREASED | 1 0.01 11.54 BLOOD CALCIUM INCREASED | 1 0.01 11.55 BLOOD CHLORIDE DECREASED | 2 0.02 11.57 BLOOD CHOLESTEROL | 1 0.01 11.58 BLOOD CHOLESTEROL ABNORMAL | 1 0.01 11.59 BLOOD CHOLESTEROL INCREASED | 14 0.14 11.73 BLOOD COUNT ABNORMAL | 2 0.02 11.75 BLOOD CREATINE PHOSPHOKINASE DECREASED | 1 0.01 11.76 BLOOD CREATINE PHOSPHOKINASE INCREASED | 7 0.07 11.83 BLOOD CREATINE PHOSPHOKINASE MB INCRE.. | 1 0.01 11.84 BLOOD CREATININE DECREASED | 1 0.01 11.85 BLOOD CREATININE INCREASED | 16 0.16 12.01 BLOOD GLUCOSE | 1 0.01 12.02 BLOOD GLUCOSE ABNORMAL | 1 0.01 12.03 BLOOD GLUCOSE DECREASED | 5 0.05 12.08 BLOOD GLUCOSE FLUCTUATION | 1 0.01 12.09 BLOOD GLUCOSE INCREASED | 21 0.21 12.30 BLOOD HUMAN CHORIONIC GONADOTROPIN IN.. | 1 0.01 12.31 BLOOD LACTATE DEHYDROGENASE INCREASED | 4 0.04 12.35 BLOOD LACTIC ACID INCREASED | 1 0.01 12.36 BLOOD OSMOLARITY DECREASED | 1 0.01 12.37 BLOOD PHOSPHORUS DECREASED | 2 0.02 12.39 BLOOD POTASSIUM ABNORMAL | 1 0.01 12.40 BLOOD POTASSIUM DECREASED | 9 0.09 12.49 BLOOD POTASSIUM INCREASED | 2 0.02 12.51 BLOOD PRESSURE DECREASED | 8 0.08 12.59 BLOOD PRESSURE FLUCTUATION | 4 0.04 12.63 BLOOD PRESSURE INADEQUATELY CONTROLLED | 2 0.02 12.65 BLOOD PRESSURE INCREASED | 18 0.18 12.83 BLOOD PRESSURE SYSTOLIC DECREASED | 1 0.01 12.84 BLOOD PRESSURE SYSTOLIC INCREASED | 2 0.02 12.86 BLOOD PROLACTIN INCREASED | 2 0.02 12.88 BLOOD SODIUM ABNORMAL | 1 0.01 12.89 BLOOD SODIUM DECREASED | 5 0.05 12.94 BLOOD TEST ABNORMAL | 1 0.01 12.95 BLOOD THYROID STIMULATING HORMONE INC.. | 2 0.02 12.97 BLOOD TRIGLYCERIDES INCREASED | 6 0.06 13.03 BLOOD UREA DECREASED | 4 0.04 13.07 BLOOD UREA INCREASED | 4 0.04 13.11 BLOOD URIC ACID INCREASED | 1 0.01 13.12 BLOOD URINE PRESENT | 5 0.05 13.17 BODY DYSMORPHIC DISORDER | 1 0.01 13.18 BODY HEIGHT DECREASED | 2 0.02 13.20 BODY TEMPERATURE DECREASED | 1 0.01 13.21 BODY TEMPERATURE INCREASED | 3 0.03 13.24 BONE ABSCESS | 1 0.01 13.25 BONE DEBRIDEMENT | 2 0.02 13.27 BONE DENSITY DECREASED | 12 0.12 13.39 BONE DISORDER | 22 0.22 13.61 BONE EROSION | 1 0.01 13.62 BONE FRAGMENTATION | 1 0.01 13.63 BONE GRAFT | 2 0.02 13.65 BONE LESION | 6 0.06 13.71 BONE LESION EXCISION | 1 0.01 13.72 BONE MARROW DISORDER | 1 0.01 13.73 BONE MARROW FAILURE | 2 0.02 13.75 BONE MARROW TRANSPLANT | 1 0.01 13.76 BONE NEOPLASM | 1 0.01 13.77 BONE NEOPLASM MALIGNANT | 1 0.01 13.78 BONE OPERATION | 1 0.01 13.79 BONE PAIN | 6 0.06 13.85 BONE SARCOMA | 2 0.02 13.87 BONE SWELLING | 1 0.01 13.88 BORDERLINE LEPROSY | 1 0.01 13.89 BRADYARRHYTHMIA | 2 0.02 13.91 BRADYCARDIA | 1 0.01 13.92 BRADYPHRENIA | 1 0.01 13.93 BRAIN CONTUSION | 1 0.01 13.94 BRAIN DEATH | 1 0.01 13.95 BRAIN HERNIATION | 1 0.01 13.96 BRAIN INJURY | 4 0.04 14.00 BRAIN MASS | 1 0.01 14.01 BRAIN NEOPLASM | 3 0.03 14.04 BRAIN NEOPLASM MALIGNANT | 2 0.02 14.06 BRAIN OEDEMA | 1 0.01 14.07 BREAKTHROUGH PAIN | 2 0.02 14.09 BREAST ABSCESS | 1 0.01 14.10 BREAST CALCIFICATIONS | 1 0.01 14.11 BREAST CANCER | 19 0.19 14.30 BREAST CANCER FEMALE | 5 0.05 14.35 BREAST CANCER METASTATIC | 4 0.04 14.39 BREAST CANCER STAGE I | 1 0.01 14.40 BREAST CYST | 1 0.01 14.41 BREAST DISCHARGE | 1 0.01 14.42 BREAST LUMP REMOVAL | 2 0.02 14.44 BREAST OPERATION | 1 0.01 14.45 BREAST PAIN | 4 0.04 14.49 BREAST SWELLING | 1 0.01 14.50 BREAST TENDERNESS | 1 0.01 14.51 BREATH ODOUR | 2 0.02 14.53 BRONCHIAL DISORDER | 1 0.01 14.54 BRONCHIAL SECRETION RETENTION | 1 0.01 14.55 BRONCHIECTASIS | 2 0.02 14.57 BRONCHIOLITIS | 1 0.01 14.58 BRONCHITIS | 9 0.09 14.67 BRONCHITIS CHRONIC | 2 0.02 14.69 BRONCHOPNEUMONIA | 4 0.04 14.73 BRONCHOSPASM | 3 0.03 14.76 BRONCHOSTENOSIS | 1 0.01 14.77 BUNDLE BRANCH BLOCK LEFT | 5 0.05 14.82 BUNDLE BRANCH BLOCK RIGHT | 2 0.02 14.84 BUNION | 2 0.02 14.86 BURNING SENSATION | 12 0.12 14.98 BURNS SECOND DEGREE | 2 0.02 15.00 BURNS THIRD DEGREE | 1 0.01 15.01 BURSA INJURY | 1 0.01 15.02 BURSITIS | 6 0.06 15.08 C-REACTIVE PROTEIN INCREASED | 4 0.04 15.12 CACHEXIA | 2 0.02 15.14 CAECITIS | 1 0.01 15.15 CAESAREAN SECTION | 3 0.03 15.18 CALCINOSIS | 1 0.01 15.19 CAMPYLOBACTER INTESTINAL INFECTION | 1 0.01 15.20 CANDIDIASIS | 2 0.02 15.22 CAPILLARY LEAK SYNDROME | 1 0.01 15.23 CARCINOGENIC EFFECT IN OFFSPRING | 1 0.01 15.24 CARCINOID TUMOUR | 1 0.01 15.25 CARDIAC ARREST | 13 0.13 15.38 CARDIAC DEATH | 1 0.01 15.39 CARDIAC DISORDER | 20 0.20 15.59 CARDIAC FAILURE | 11 0.11 15.70 CARDIAC FAILURE CHRONIC | 1 0.01 15.71 CARDIAC FAILURE CONGESTIVE | 25 0.25 15.96 CARDIAC FLUTTER | 2 0.02 15.98 CARDIAC HYPERTROPHY | 2 0.02 16.00 CARDIAC INFECTION | 1 0.01 16.01 CARDIAC MURMUR | 4 0.04 16.05 CARDIAC OPERATION | 3 0.03 16.08 CARDIAC OUTPUT DECREASED | 1 0.01 16.09 CARDIAC PACEMAKER INSERTION | 2 0.02 16.11 CARDIAC TAMPONADE | 1 0.01 16.12 CARDIAC VALVE DISEASE | 2 0.02 16.14 CARDIO-RESPIRATORY ARREST | 7 0.07 16.21 CARDIOACTIVE DRUG LEVEL INCREASED | 1 0.01 16.22 CARDIOMEGALY | 6 0.06 16.28 CARDIOMYOPATHY | 2 0.02 16.30 CARDIOVASCULAR DISORDER | 1 0.01 16.31 CAROTID ARTERY DISEASE | 2 0.02 16.33 CAROTID ARTERY OCCLUSION | 2 0.02 16.35 CAROTID SINUS SYNDROME | 1 0.01 16.36 CARPAL TUNNEL SYNDROME | 4 0.04 16.40 CARTILAGE INJURY | 1 0.01 16.41 CASTLEMAN'S DISEASE | 1 0.01 16.42 CATARACT | 11 0.11 16.53 CATARACT OPERATION | 5 0.05 16.58 CATHETER PLACEMENT | 1 0.01 16.59 CATHETER REMOVAL | 1 0.01 16.60 CATHETER SITE SWELLING | 1 0.01 16.61 CATHETERISATION CARDIAC | 1 0.01 16.62 CD4 LYMPHOCYTES DECREASED | 1 0.01 16.63 CELLULITIS | 10 0.10 16.73 CENTRAL NERVOUS SYSTEM LESION | 6 0.06 16.79 CENTRAL VENOUS CATHETERISATION | 1 0.01 16.80 CEREBRAL ARTERY EMBOLISM | 1 0.01 16.81 CEREBRAL ATROPHY | 2 0.02 16.83 CEREBRAL HAEMORRHAGE | 10 0.10 16.93 CEREBRAL HAEMORRHAGE TRAUMATIC | 1 0.01 16.94 CEREBRAL INFARCTION | 5 0.05 16.99 CEREBRAL ISCHAEMIA | 2 0.02 17.01 CEREBRAL VENOUS THROMBOSIS | 1 0.01 17.02 CEREBROSPINAL FLUID RHINORRHOEA | 3 0.03 17.05 CEREBROVASCULAR ACCIDENT | 33 0.33 17.38 CEREBROVASCULAR DISORDER | 1 0.01 17.39 CERVICAL CORD COMPRESSION | 1 0.01 17.40 CERVICAL DYSPLASIA | 1 0.01 17.41 CERVICAL MYELOPATHY | 1 0.01 17.42 CERVIX CARCINOMA | 3 0.03 17.45 CERVIX CARCINOMA STAGE III | 1 0.01 17.46 CERVIX DISORDER | 1 0.01 17.47 CHANGE OF BOWEL HABIT | 1 0.01 17.48 CHAPPED LIPS | 1 0.01 17.49 CHEILITIS | 2 0.02 17.51 CHEMICAL INJURY | 1 0.01 17.52 CHEMOTHERAPY | 1 0.01 17.53 CHEST DISCOMFORT | 11 0.11 17.64 CHEST PAIN | 45 0.45 18.09 CHILLS | 17 0.17 18.26 CHLOROMA | 1 0.01 18.27 CHOKING | 3 0.03 18.30 CHOKING SENSATION | 1 0.01 18.31 CHOLECYSTECTOMY | 10 0.10 18.41 CHOLECYSTITIS | 5 0.05 18.46 CHOLECYSTITIS ACUTE | 3 0.03 18.49 CHOLECYSTITIS CHRONIC | 15 0.15 18.64 CHOLELITHIASIS | 23 0.23 18.87 CHOLESTASIS | 1 0.01 18.88 CHONDROCALCINOSIS PYROPHOSPHATE | 1 0.01 18.89 CHONDROMALACIA | 1 0.01 18.90 CHOREOATHETOSIS | 1 0.01 18.91 CHOROIDITIS | 1 0.01 18.92 CHROMATURIA | 5 0.05 18.97 CHRONIC HEPATIC FAILURE | 1 0.01 18.98 CHRONIC LYMPHOCYTIC LEUKAEMIA | 4 0.04 19.02 CHRONIC MYELOID LEUKAEMIA | 4 0.04 19.06 CHRONIC MYELOID LEUKAEMIA TRANSFORMAT.. | 1 0.01 19.07 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 15 0.15 19.22 CHRONIC SINUSITIS | 4 0.04 19.26 CHYLOTHORAX | 1 0.01 19.27 CIRCULATORY COLLAPSE | 6 0.06 19.33 CLOSTRIDIAL INFECTION | 1 0.01 19.34 COAGULATION FACTOR DEFICIENCY | 1 0.01 19.35 COAGULOPATHY | 4 0.04 19.39 COARCTATION OF THE AORTA | 1 0.01 19.40 COCCIDIOIDOMYCOSIS | 2 0.02 19.42 COELIAC DISEASE | 1 0.01 19.43 COGNITIVE DISORDER | 20 0.20 19.63 COLD SWEAT | 4 0.04 19.67 COLD TYPE HAEMOLYTIC ANAEMIA | 1 0.01 19.68 COLECTOMY | 2 0.02 19.70 COLITIS | 4 0.04 19.74 COLITIS COLLAGENOUS | 2 0.02 19.76 COLITIS EROSIVE | 1 0.01 19.77 COLITIS ISCHAEMIC | 2 0.02 19.79 COLITIS ULCERATIVE | 3 0.03 19.82 COLLAPSE OF LUNG | 2 0.02 19.84 COLON CANCER | 3 0.03 19.87 COLON NEOPLASM | 1 0.01 19.88 COLONIC POLYP | 1 0.01 19.89 COLONIC STENOSIS | 1 0.01 19.90 COLONOSCOPY | 1 0.01 19.91 COLOSTOMY | 1 0.01 19.92 COMA | 10 0.10 20.02 COMPARTMENT SYNDROME | 1 0.01 20.03 COMPLETED SUICIDE | 6 0.06 20.09 COMPLEX REGIONAL PAIN SYNDROME | 1 0.01 20.10 COMPRESSION FRACTURE | 7 0.07 20.17 COMPULSIVE SHOPPING | 1 0.01 20.18 CONCOMITANT DISEASE PROGRESSION | 3 0.03 20.21 CONCUSSION | 2 0.02 20.23 CONDITION AGGRAVATED | 20 0.20 20.43 CONDUCTION DISORDER | 3 0.03 20.46 CONFUSIONAL STATE | 33 0.33 20.79 CONGENITAL ABSENCE OF BILE DUCTS | 1 0.01 20.80 CONGENITAL ANOMALY IN OFFSPRING | 1 0.01 20.81 CONGENITAL CENTRAL NERVOUS SYSTEM ANO.. | 1 0.01 20.82 CONGENITAL HEPATOBILIARY ANOMALY | 1 0.01 20.83 CONGENITAL PULMONARY VALVE ATRESIA | 1 0.01 20.84 CONGENITAL SMALL INTESTINAL ATRESIA | 1 0.01 20.85 CONGENITAL TRICUSPID VALVE ATRESIA | 1 0.01 20.86 CONJUNCTIVAL HAEMORRHAGE | 1 0.01 20.87 CONJUNCTIVITIS | 3 0.03 20.90 CONJUNCTIVITIS ALLERGIC | 1 0.01 20.91 CONSTIPATION | 15 0.15 21.06 CONTINUOUS HAEMODIAFILTRATION | 2 0.02 21.08 CONTRAST MEDIA ALLERGY | 1 0.01 21.09 CONTRAST MEDIA REACTION | 1 0.01 21.10 CONTUSION | 11 0.11 21.21 CONVULSION | 37 0.37 21.58 COOMBS POSITIVE HAEMOLYTIC ANAEMIA | 2 0.02 21.60 COORDINATION ABNORMAL | 2 0.02 21.62 CORNEAL DISORDER | 1 0.01 21.63 CORONARY ARTERY BYPASS | 2 0.02 21.65 CORONARY ARTERY DISEASE | 10 0.10 21.75 CORONARY ARTERY OCCLUSION | 5 0.05 21.80 CORONARY ARTERY RESTENOSIS | 1 0.01 21.81 CORONARY ARTERY STENOSIS | 1 0.01 21.82 COSTOCHONDRITIS | 2 0.02 21.84 COUGH | 30 0.30 22.14 COW'S MILK INTOLERANCE | 1 0.01 22.15 CREPITATIONS | 1 0.01 22.16 CROHN'S DISEASE | 17 0.17 22.33 CRYING | 8 0.08 22.41 CSF PROTEIN INCREASED | 1 0.01 22.42 CYANOSIS | 1 0.01 22.43 CYST | 2 0.02 22.45 CYSTITIS | 7 0.07 22.52 CYSTITIS HAEMORRHAGIC | 1 0.01 22.53 CYSTITIS INTERSTITIAL | 3 0.03 22.56 CYSTITIS NONINFECTIVE | 1 0.01 22.57 CYTOLYTIC HEPATITIS | 1 0.01 22.58 CYTOMEGALOVIRUS CHORIORETINITIS | 1 0.01 22.59 CYTOMEGALOVIRUS ENTEROCOLITIS | 1 0.01 22.60 CYTOMEGALOVIRUS INFECTION | 4 0.04 22.64 DACRYOSTENOSIS ACQUIRED | 1 0.01 22.65 DEAFNESS | 6 0.06 22.71 DEAFNESS BILATERAL | 2 0.02 22.73 DEAFNESS NEUROSENSORY | 1 0.01 22.74 DEAFNESS UNILATERAL | 2 0.02 22.76 DEATH | 77 0.77 23.53 DEATH OF RELATIVE | 1 0.01 23.54 DEBRIDEMENT | 2 0.02 23.56 DECREASED ACTIVITY | 1 0.01 23.57 DECREASED APPETITE | 33 0.33 23.90 DECREASED IMMUNE RESPONSIVENESS | 1 0.01 23.91 DECREASED INTEREST | 17 0.17 24.08 DECUBITUS ULCER | 3 0.03 24.11 DEEP VEIN THROMBOSIS | 20 0.20 24.31 DEFORMITY | 15 0.15 24.46 DEHYDRATION | 19 0.19 24.65 DELIRIUM | 4 0.04 24.69 DELIVERY | 1 0.01 24.70 DELUSION | 2 0.02 24.72 DEMENTIA | 1 0.01 24.73 DEMENTIA ALZHEIMER'S TYPE | 2 0.02 24.75 DENTAL CARE | 2 0.02 24.77 DENTAL CARIES | 8 0.08 24.85 DENTAL FISTULA | 2 0.02 24.87 DENTAL IMPLANTATION | 1 0.01 24.88 DENTAL OPERATION | 2 0.02 24.90 DENTAL PROSTHESIS USER | 1 0.01 24.91 DENTAL PULP DISORDER | 1 0.01 24.92 DENTURE WEARER | 2 0.02 24.94 DEPRESSED LEVEL OF CONSCIOUSNESS | 7 0.07 25.01 DEPRESSED MOOD | 9 0.09 25.10 DEPRESSION | 62 0.62 25.72 DEPRESSION SUICIDAL | 1 0.01 25.73 DEPRESSIVE SYMPTOM | 1 0.01 25.74 DERMAL CYST | 1 0.01 25.75 DERMATITIS | 4 0.04 25.79 DERMATITIS BULLOUS | 2 0.02 25.81 DERMATITIS CONTACT | 2 0.02 25.83 DERMATITIS EXFOLIATIVE | 1 0.01 25.84 DERMATITIS INFECTED | 1 0.01 25.85 DERMATOPHYTOSIS | 1 0.01 25.86 DETACHMENT OF RETINAL PIGMENT EPITHEL.. | 1 0.01 25.87 DEVELOPMENTAL DELAY | 2 0.02 25.89 DEVICE BREAKAGE | 4 0.04 25.93 DEVICE DAMAGE | 1 0.01 25.94 DEVICE DISLOCATION | 17 0.17 26.11 DEVICE EXPULSION | 34 0.34 26.45 DEVICE INEFFECTIVE | 1 0.01 26.46 DEVICE INTOLERANCE | 1 0.01 26.47 DEVICE MALFUNCTION | 7 0.07 26.54 DEVICE OCCLUSION | 2 0.02 26.56 DEVICE RELATED INFECTION | 1 0.01 26.57 DEVICE RELATED SEPSIS | 1 0.01 26.58 DIABETES MELLITUS | 23 0.23 26.81 DIABETES MELLITUS INADEQUATE CONTROL | 9 0.09 26.90 DIABETES MELLITUS MANAGEMENT | 1 0.01 26.91 DIABETIC COMA | 1 0.01 26.92 DIABETIC GASTROPARESIS | 2 0.02 26.94 DIABETIC GASTROPATHY | 1 0.01 26.95 DIABETIC KETOACIDOSIS | 4 0.04 26.99 DIABETIC NEPHROPATHY | 1 0.01 27.00 DIABETIC NEUROPATHY | 5 0.05 27.05 DIABETIC RETINOPATHY | 2 0.02 27.07 DIALYSIS | 1 0.01 27.08 DIARRHOEA | 69 0.69 27.77 DIARRHOEA HAEMORRHAGIC | 2 0.02 27.79 DIHYDROPYRIMIDINE DEHYDROGENASE DEFIC.. | 1 0.01 27.80 DILATATION INTRAHEPATIC DUCT ACQUIRED | 1 0.01 27.81 DIPLOPIA | 9 0.09 27.90 DISABILITY | 14 0.14 28.04 DISBACTERIOSIS | 1 0.01 28.05 DISCOMFORT | 4 0.04 28.09 DISEASE PROGRESSION | 11 0.11 28.20 DISLOCATION OF STERNUM | 1 0.01 28.21 DISORIENTATION | 5 0.05 28.26 DISSEMINATED INTRAVASCULAR COAGULATION | 4 0.04 28.30 DISSOCIATION | 1 0.01 28.31 DISTURBANCE IN ATTENTION | 8 0.08 28.39 DIVERTICULAR PERFORATION | 2 0.02 28.41 DIVERTICULITIS | 7 0.07 28.48 DIVERTICULUM | 3 0.03 28.51 DIVERTICULUM INTESTINAL | 1 0.01 28.52 DIZZINESS | 79 0.79 29.31 DOPAMINE DYSREGULATION SYNDROME | 1 0.01 29.32 DROWNING | 1 0.01 29.33 DRUG ABUSE | 4 0.04 29.37 DRUG ADMINISTERED AT INAPPROPRIATE SITE | 5 0.05 29.42 DRUG ADMINISTRATION ERROR | 5 0.05 29.47 DRUG DEPENDENCE | 4 0.04 29.51 DRUG DETOXIFICATION | 1 0.01 29.52 DRUG DISPENSING ERROR | 2 0.02 29.54 DRUG DOSE OMISSION | 11 0.11 29.65 DRUG EFFECT DECREASED | 12 0.12 29.77 DRUG EFFECT DELAYED | 1 0.01 29.78 DRUG EFFECT INCREASED | 1 0.01 29.79 DRUG ERUPTION | 3 0.03 29.82 DRUG EXPOSURE DURING PREGNANCY | 32 0.32 30.14 DRUG HYPERSENSITIVITY | 7 0.07 30.21 DRUG INEFFECTIVE | 130 1.30 31.51 DRUG INTERACTION | 26 0.26 31.77 DRUG INTOLERANCE | 7 0.07 31.84 DRUG LEVEL ABOVE THERAPEUTIC | 1 0.01 31.85 DRUG LEVEL INCREASED | 6 0.06 31.91 DRUG PRESCRIBING ERROR | 6 0.06 31.97 DRUG RASH WITH EOSINOPHILIA AND SYSTE.. | 1 0.01 31.98 DRUG SCREEN FALSE POSITIVE | 4 0.04 32.02 DRUG SCREEN NEGATIVE | 1 0.01 32.03 DRUG SPECIFIC ANTIBODY PRESENT | 5 0.05 32.08 DRUG TOXICITY | 11 0.11 32.19 DRUG WITHDRAWAL SYNDROME | 10 0.10 32.29 DRY EYE | 1 0.01 32.30 DRY MOUTH | 9 0.09 32.39 DRY SKIN | 2 0.02 32.41 DUODENAL ULCER | 3 0.03 32.44 DUODENAL ULCER HAEMORRHAGE | 1 0.01 32.45 DUODENAL ULCER PERFORATION | 1 0.01 32.46 DUODENITIS | 3 0.03 32.49 DYSAESTHESIA | 1 0.01 32.50 DYSARTHRIA | 5 0.05 32.55 DYSFUNCTIONAL UTERINE BLEEDING | 2 0.02 32.57 DYSGEUSIA | 4 0.04 32.61 DYSGRAPHIA | 5 0.05 32.66 DYSKINESIA | 8 0.08 32.74 DYSLEXIA | 1 0.01 32.75 DYSLIPIDAEMIA | 1 0.01 32.76 DYSMENORRHOEA | 1 0.01 32.77 DYSPEPSIA | 10 0.10 32.87 DYSPHAGIA | 12 0.12 32.99 DYSPHEMIA | 2 0.02 33.01 DYSPHONIA | 7 0.07 33.08 DYSPHORIA | 1 0.01 33.09 DYSPLASIA | 1 0.01 33.10 DYSPNOEA | 80 0.80 33.90 DYSPNOEA EXERTIONAL | 7 0.07 33.97 DYSSTASIA | 12 0.12 34.09 DYSTONIA | 1 0.01 34.10 DYSURIA | 8 0.08 34.18 EAR DISCOMFORT | 1 0.01 34.19 EAR DISORDER | 2 0.02 34.21 EAR INFECTION | 2 0.02 34.23 EAR IRRIGATION | 1 0.01 34.24 EAR MALFORMATION | 1 0.01 34.25 EAR PAIN | 3 0.03 34.28 EAR PRURITUS | 1 0.01 34.29 EATING DISORDER | 6 0.06 34.35 ECTOPIC PREGNANCY | 1 0.01 34.36 ECZEMA | 5 0.05 34.41 EDENTULOUS | 2 0.02 34.43 EFFUSION | 2 0.02 34.45 EJACULATION DELAYED | 1 0.01 34.46 EJACULATION FAILURE | 1 0.01 34.47 EJECTION FRACTION DECREASED | 3 0.03 34.50 ELECTROCARDIOGRAM ABNORMAL | 1 0.01 34.51 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED | 1 0.01 34.52 ELECTROCARDIOGRAM QT PROLONGED | 6 0.06 34.58 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION | 1 0.01 34.59 ELECTROLYTE IMBALANCE | 2 0.02 34.61 EMBOLIC STROKE | 1 0.01 34.62 EMBOLISM ARTERIAL | 1 0.01 34.63 EMOTIONAL DISORDER | 6 0.06 34.69 EMOTIONAL DISTRESS | 12 0.12 34.81 EMPHYSEMA | 2 0.02 34.83 EMPYEMA | 1 0.01 34.84 ENAMEL ANOMALY | 1 0.01 34.85 ENCEPHALITIS | 3 0.03 34.88 ENCEPHALITIS HERPES | 1 0.01 34.89 ENCEPHALOMALACIA | 1 0.01 34.90 ENCEPHALOPATHY | 5 0.05 34.95 ENDOCARDITIS | 2 0.02 34.97 ENDODONTIC PROCEDURE | 2 0.02 34.99 ENDOMETRIAL CANCER | 1 0.01 35.00 ENDOMETRIAL HYPERPLASIA | 1 0.01 35.01 ENDOMETRIAL HYPERTROPHY | 1 0.01 35.02 ENDOTRACHEAL INTUBATION | 2 0.02 35.04 ENDOTRACHEAL INTUBATION COMPLICATION | 1 0.01 35.05 ENTERITIS INFECTIOUS | 1 0.01 35.06 ENTEROBACTER BACTERAEMIA | 1 0.01 35.07 ENTEROCOCCUS TEST POSITIVE | 1 0.01 35.08 ENTEROCOLITIS HAEMORRHAGIC | 1 0.01 35.09 ENTEROCOLITIS VIRAL | 1 0.01 35.10 ENTEROCUTANEOUS FISTULA | 1 0.01 35.11 ENTHESOPATHY | 1 0.01 35.12 EOSINOPHIL COUNT INCREASED | 3 0.03 35.15 EOSINOPHIL PERCENTAGE INCREASED | 1 0.01 35.16 EOSINOPHILIA | 5 0.05 35.21 EOSINOPHILIC PNEUMONIA | 2 0.02 35.23 EPICONDYLITIS | 2 0.02 35.25 EPIGASTRIC DISCOMFORT | 1 0.01 35.26 EPILEPSY | 3 0.03 35.29 EPIPLOIC APPENDAGITIS | 1 0.01 35.30 EPISTAXIS | 6 0.06 35.36 EPSTEIN-BARR VIRAEMIA | 1 0.01 35.37 EPSTEIN-BARR VIRUS INFECTION | 1 0.01 35.38 ERECTILE DYSFUNCTION | 7 0.07 35.45 ERECTION INCREASED | 2 0.02 35.47 ERUCTATION | 1 0.01 35.48 ERYSIPELAS | 1 0.01 35.49 ERYTHEMA | 15 0.15 35.64 ERYTHEMA MULTIFORME | 6 0.06 35.70 ESCHERICHIA SEPSIS | 1 0.01 35.71 ESCHERICHIA URINARY TRACT INFECTION | 1 0.01 35.72 EUPHORIC MOOD | 1 0.01 35.73 EVANS SYNDROME | 1 0.01 35.74 EXAGGERATED STARTLE RESPONSE | 1 0.01 35.75 EXCORIATION | 4 0.04 35.79 EXECUTIVE DYSFUNCTION | 1 0.01 35.80 EXFOLIATIVE RASH | 2 0.02 35.82 EXOSTOSIS | 5 0.05 35.87 EXPIRED DRUG ADMINISTERED | 2 0.02 35.89 EXPOSURE TO CONTAMINATED DEVICE | 2 0.02 35.91 EXTERNAL EAR CELLULITIS | 1 0.01 35.92 EXTRADURAL HAEMATOMA | 1 0.01 35.93 EXTRAPYRAMIDAL DISORDER | 1 0.01 35.94 EXTRASYSTOLES | 1 0.01 35.95 EXTREMITY NECROSIS | 1 0.01 35.96 EYE DISORDER | 2 0.02 35.98 EYE HAEMORRHAGE | 4 0.04 36.02 EYE INFLAMMATION | 1 0.01 36.03 EYE IRRITATION | 1 0.01 36.04 EYE MOVEMENT DISORDER | 1 0.01 36.05 EYE OPERATION | 1 0.01 36.06 EYE PAIN | 3 0.03 36.09 EYE SWELLING | 3 0.03 36.12 EYELID IRRITATION | 1 0.01 36.13 EYELID MARGIN CRUSTING | 1 0.01 36.14 EYELID OEDEMA | 1 0.01 36.15 EYELID PTOSIS | 2 0.02 36.17 FACE INJURY | 1 0.01 36.18 FACE OEDEMA | 6 0.06 36.24 FACIAL PAIN | 2 0.02 36.26 FACIAL PARESIS | 3 0.03 36.29 FACTOR VIII DEFICIENCY | 2 0.02 36.31 FACTOR VIII INHIBITION | 1 0.01 36.32 FAECAL INCONTINENCE | 3 0.03 36.35 FAECALOMA | 2 0.02 36.37 FAECES DISCOLOURED | 2 0.02 36.39 FAILED INDUCTION OF LABOUR | 1 0.01 36.40 FAILURE TO THRIVE | 3 0.03 36.43 FALL | 81 0.81 37.24 FALLOT'S TETRALOGY | 1 0.01 37.25 FAMILY STRESS | 2 0.02 37.27 FANCONI SYNDROME ACQUIRED | 1 0.01 37.28 FASCIITIS | 1 0.01 37.29 FATIGUE | 139 1.39 38.68 FEAR | 5 0.05 38.73 FEBRILE NEUTROPENIA | 8 0.08 38.81 FEEDING DISORDER NEONATAL | 1 0.01 38.82 FEEDING DISORDER OF INFANCY OR EARLY .. | 1 0.01 38.83 FEELING ABNORMAL | 43 0.43 39.26 FEELING COLD | 1 0.01 39.27 FEELING HOT | 14 0.14 39.41 FEELING JITTERY | 3 0.03 39.44 FEMORAL NECK FRACTURE | 1 0.01 39.45 FEMUR FRACTURE | 7 0.07 39.52 FIBROCYSTIC BREAST DISEASE | 1 0.01 39.53 FIBROMYALGIA | 6 0.06 39.59 FIBROUS DYSPLASIA OF BONE | 1 0.01 39.60 FIBULA FRACTURE | 3 0.03 39.63 FILARIASIS | 1 0.01 39.64 FINGER DEFORMITY | 1 0.01 39.65 FISTULA | 4 0.04 39.69 FISTULA DISCHARGE | 3 0.03 39.72 FLANK PAIN | 4 0.04 39.76 FLAT AFFECT | 1 0.01 39.77 FLATULENCE | 8 0.08 39.85 FLUID INTAKE RESTRICTION | 1 0.01 39.86 FLUID OVERLOAD | 1 0.01 39.87 FLUID RETENTION | 12 0.12 39.99 FLUSHING | 5 0.05 40.04 FOCAL SEGMENTAL GLOMERULOSCLEROSIS | 1 0.01 40.05 FOETAL DISTRESS SYNDROME | 2 0.02 40.07 FOETAL GROWTH RESTRICTION | 2 0.02 40.09 FOOD ALLERGY | 1 0.01 40.10 FOOD CRAVING | 2 0.02 40.12 FOOD INTOLERANCE | 1 0.01 40.13 FOOD POISONING | 1 0.01 40.14 FOOT AMPUTATION | 1 0.01 40.15 FOOT FRACTURE | 6 0.06 40.21 FOOT OPERATION | 1 0.01 40.22 FOREIGN BODY | 3 0.03 40.25 FORMICATION | 5 0.05 40.30 FRACTURE | 5 0.05 40.35 FRACTURE NONUNION | 1 0.01 40.36 FRACTURED SACRUM | 2 0.02 40.38 FRUSTRATION | 2 0.02 40.40 FULL BLOOD COUNT DECREASED | 1 0.01 40.41 FULL BLOOD COUNT INCREASED | 1 0.01 40.42 FUMBLING | 1 0.01 40.43 FUNGAL INFECTION | 5 0.05 40.48 GAIT DISTURBANCE | 49 0.49 40.97 GALACTORRHOEA | 3 0.03 41.00 GALLBLADDER CHOLESTEROLOSIS | 3 0.03 41.03 GALLBLADDER DISORDER | 21 0.21 41.24 GALLBLADDER INJURY | 2 0.02 41.26 GALLBLADDER NON-FUNCTIONING | 2 0.02 41.28 GALLBLADDER OPERATION | 2 0.02 41.30 GAMMA-GLUTAMYLTRANSFERASE INCREASED | 6 0.06 41.36 GASTRIC BYPASS | 2 0.02 41.38 GASTRIC CANCER | 1 0.01 41.39 GASTRIC DISORDER | 9 0.09 41.48 GASTRIC FISTULA | 1 0.01 41.49 GASTRIC HAEMORRHAGE | 1 0.01 41.50 GASTRIC OPERATION | 1 0.01 41.51 GASTRIC POLYPS | 1 0.01 41.52 GASTRIC ULCER | 5 0.05 41.57 GASTRIC ULCER HAEMORRHAGE | 1 0.01 41.58 GASTRITIS | 4 0.04 41.62 GASTROENTERITIS VIRAL | 5 0.05 41.67 GASTROINTESTINAL DISORDER | 7 0.07 41.74 GASTROINTESTINAL ENDOSCOPIC THERAPY | 1 0.01 41.75 GASTROINTESTINAL EROSION | 1 0.01 41.76 GASTROINTESTINAL HAEMORRHAGE | 5 0.05 41.81 GASTROINTESTINAL MALFORMATION | 1 0.01 41.82 GASTROINTESTINAL MOTILITY DISORDER | 1 0.01 41.83 GASTROINTESTINAL NECROSIS | 2 0.02 41.85 GASTROINTESTINAL PAIN | 2 0.02 41.87 GASTROINTESTINAL PERFORATION | 2 0.02 41.89 GASTROINTESTINAL STROMAL TUMOUR | 1 0.01 41.90 GASTROINTESTINAL TOXICITY | 1 0.01 41.91 GASTROINTESTINAL TUBE INSERTION | 2 0.02 41.93 GASTROOESOPHAGEAL REFLUX DISEASE | 6 0.06 41.99 GAZE PALSY | 1 0.01 42.00 GENERAL PHYSICAL CONDITION ABNORMAL | 1 0.01 42.01 GENERAL PHYSICAL HEALTH DETERIORATION | 24 0.24 42.25 GENERAL SYMPTOM | 5 0.05 42.30 GENERALISED OEDEMA | 2 0.02 42.32 GENITAL DISCHARGE | 1 0.01 42.33 GENITAL HAEMORRHAGE | 1 0.01 42.34 GENITAL HERPES | 1 0.01 42.35 GINGIVAL BLEEDING | 5 0.05 42.40 GINGIVAL DISORDER | 4 0.04 42.44 GINGIVAL ERYTHEMA | 2 0.02 42.46 GINGIVAL INFECTION | 1 0.01 42.47 GINGIVAL OEDEMA | 1 0.01 42.48 GINGIVAL PAIN | 2 0.02 42.50 GINGIVAL RECESSION | 3 0.03 42.53 GINGIVAL SWELLING | 3 0.03 42.56 GINGIVAL ULCERATION | 1 0.01 42.57 GINGIVECTOMY | 1 0.01 42.58 GINGIVITIS | 4 0.04 42.62 GLAUCOMA | 3 0.03 42.65 GLAUCOMA SURGERY | 2 0.02 42.67 GLOMERULAR FILTRATION RATE DECREASED | 3 0.03 42.70 GLOMERULONEPHRITIS | 2 0.02 42.72 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE | 1 0.01 42.73 GLOSSODYNIA | 2 0.02 42.75 GLUCOSE TOLERANCE DECREASED | 1 0.01 42.76 GLUCOSE TOLERANCE IMPAIRED | 2 0.02 42.78 GLUCOSE URINE PRESENT | 1 0.01 42.79 GLYCOSYLATED HAEMOGLOBIN INCREASED | 1 0.01 42.80 GOITRE | 4 0.04 42.84 GOUT | 4 0.04 42.88 GRAND MAL CONVULSION | 7 0.07 42.95 GRANULOCYTOPENIA | 1 0.01 42.96 GRIP STRENGTH DECREASED | 1 0.01 42.97 GROWTH RETARDATION | 2 0.02 42.99 GUILLAIN-BARRE SYNDROME | 1 0.01 43.00 GUN SHOT WOUND | 2 0.02 43.02 GYNAECOMASTIA | 1 0.01 43.03 HAEMANGIOMA | 1 0.01 43.04 HAEMATEMESIS | 6 0.06 43.10 HAEMATOCHEZIA | 3 0.03 43.13 HAEMATOCRIT ABNORMAL | 1 0.01 43.14 HAEMATOCRIT DECREASED | 5 0.05 43.19 HAEMATOLOGICAL MALIGNANCY | 1 0.01 43.20 HAEMATOMA | 3 0.03 43.23 HAEMATOMA INFECTION | 1 0.01 43.24 HAEMATOSPERMIA | 1 0.01 43.25 HAEMATURIA | 5 0.05 43.30 HAEMODIALYSIS | 2 0.02 43.32 HAEMOGLOBIN ABNORMAL | 1 0.01 43.33 HAEMOGLOBIN DECREASED | 11 0.11 43.44 HAEMOGLOBIN INCREASED | 1 0.01 43.45 HAEMOLYTIC ANAEMIA | 2 0.02 43.47 HAEMOLYTIC URAEMIC SYNDROME | 3 0.03 43.50 HAEMOPTYSIS | 6 0.06 43.56 HAEMORRHAGE | 11 0.11 43.67 HAEMORRHAGE INTRACRANIAL | 1 0.01 43.68 HAEMORRHAGE URINARY TRACT | 1 0.01 43.69 HAEMORRHAGIC DISORDER | 1 0.01 43.70 HAEMORRHAGIC STROKE | 4 0.04 43.74 HAEMORRHOIDAL HAEMORRHAGE | 1 0.01 43.75 HAEMORRHOIDS | 5 0.05 43.80 HAEMOTHORAX | 1 0.01 43.81 HAIR COLOUR CHANGES | 1 0.01 43.82 HAIR TEXTURE ABNORMAL | 1 0.01 43.83 HALLUCINATION | 10 0.10 43.93 HALLUCINATION, AUDITORY | 8 0.08 44.01 HALLUCINATION, VISUAL | 2 0.02 44.03 HAND FRACTURE | 2 0.02 44.05 HEAD DISCOMFORT | 1 0.01 44.06 HEAD INJURY | 6 0.06 44.12 HEADACHE | 84 0.84 44.96 HEARING IMPAIRED | 6 0.06 45.02 HEART DISEASE CONGENITAL | 1 0.01 45.03 HEART RATE ABNORMAL | 1 0.01 45.04 HEART RATE DECREASED | 6 0.06 45.10 HEART RATE INCREASED | 8 0.08 45.18 HEART RATE IRREGULAR | 3 0.03 45.21 HEART VALVE INCOMPETENCE | 3 0.03 45.24 HEART VALVE REPLACEMENT | 1 0.01 45.25 HEAT ILLNESS | 1 0.01 45.26 HELICOBACTER INFECTION | 1 0.01 45.27 HEMIPARESIS | 7 0.07 45.34 HEMIPLEGIA | 4 0.04 45.38 HENOCH-SCHONLEIN PURPURA | 2 0.02 45.40 HEPARIN-INDUCED THROMBOCYTOPENIA | 1 0.01 45.41 HEPATIC CIRRHOSIS | 1 0.01 45.42 HEPATIC ENCEPHALOPATHY | 5 0.05 45.47 HEPATIC ENZYME ABNORMAL | 1 0.01 45.48 HEPATIC ENZYME INCREASED | 9 0.09 45.57 HEPATIC FAILURE | 4 0.04 45.61 HEPATIC FUNCTION ABNORMAL | 9 0.09 45.70 HEPATIC NECROSIS | 1 0.01 45.71 HEPATIC NEOPLASM MALIGNANT | 3 0.03 45.74 HEPATIC STEATOSIS | 7 0.07 45.81 HEPATITIS | 5 0.05 45.86 HEPATITIS ACUTE | 1 0.01 45.87 HEPATITIS ALCOHOLIC | 1 0.01 45.88 HEPATITIS B | 1 0.01 45.89 HEPATITIS B DNA INCREASED | 1 0.01 45.90 HEPATITIS C | 3 0.03 45.93 HEPATITIS CHOLESTATIC | 1 0.01 45.94 HEPATITIS FULMINANT | 1 0.01 45.95 HEPATITIS INFECTIOUS MONONUCLEOSIS | 1 0.01 45.96 HEPATITIS TOXIC | 2 0.02 45.98 HEPATOMEGALY | 8 0.08 46.06 HEPATOTOXICITY | 3 0.03 46.09 HERNIA | 4 0.04 46.13 HERPES OPHTHALMIC | 1 0.01 46.14 HERPES SIMPLEX | 1 0.01 46.15 HERPES VIRUS INFECTION | 1 0.01 46.16 HERPES ZOSTER | 13 0.13 46.29 HIATUS HERNIA | 7 0.07 46.36 HICCUPS | 2 0.02 46.38 HIGH DENSITY LIPOPROTEIN DECREASED | 1 0.01 46.39 HIP ARTHROPLASTY | 6 0.06 46.45 HIP FRACTURE | 10 0.10 46.55 HIP SURGERY | 1 0.01 46.56 HISTIOCYTOSIS HAEMATOPHAGIC | 1 0.01 46.57 HODGKIN'S DISEASE | 2 0.02 46.59 HODGKIN'S DISEASE STAGE IV | 1 0.01 46.60 HOMANS' SIGN | 1 0.01 46.61 HORMONE LEVEL ABNORMAL | 1 0.01 46.62 HOSPICE CARE | 1 0.01 46.63 HOSPITALISATION | 37 0.37 47.00 HOSTILITY | 2 0.02 47.02 HOT FLUSH | 8 0.08 47.10 HUMAN PAPILLOMA VIRUS TEST POSITIVE | 1 0.01 47.11 HUMERUS FRACTURE | 4 0.04 47.15 HUNGER | 1 0.01 47.16 HYDROCEPHALUS | 2 0.02 47.18 HYPERBARIC OXYGEN THERAPY | 1 0.01 47.19 HYPERBILIRUBINAEMIA | 1 0.01 47.20 HYPERCALCAEMIA | 2 0.02 47.22 HYPERCHOLESTEROLAEMIA | 5 0.05 47.27 HYPERGLYCAEMIA | 5 0.05 47.32 HYPERHIDROSIS | 21 0.21 47.53 HYPERKALAEMIA | 8 0.08 47.61 HYPERKERATOSIS | 2 0.02 47.63 HYPERLIPASAEMIA | 1 0.01 47.64 HYPERLIPIDAEMIA | 3 0.03 47.67 HYPERNATRAEMIA | 1 0.01 47.68 HYPERPARATHYROIDISM PRIMARY | 1 0.01 47.69 HYPERPHAGIA | 1 0.01 47.70 HYPERPLASIA | 2 0.02 47.72 HYPERPROLACTINAEMIA | 1 0.01 47.73 HYPERPROTEINAEMIA | 1 0.01 47.74 HYPERREFLEXIA | 2 0.02 47.76 HYPERSENSITIVITY | 36 0.36 48.12 HYPERSEXUALITY | 1 0.01 48.13 HYPERSOMNIA | 8 0.08 48.21 HYPERTENSION | 45 0.45 48.66 HYPERTENSIVE CRISIS | 3 0.03 48.69 HYPERTENSIVE HEART DISEASE | 1 0.01 48.70 HYPERTHERMIA | 1 0.01 48.71 HYPERTHERMIA MALIGNANT | 1 0.01 48.72 HYPERTHYROIDISM | 1 0.01 48.73 HYPERTONIC BLADDER | 2 0.02 48.75 HYPERTRIGLYCERIDAEMIA | 4 0.04 48.79 HYPERTROPHY | 1 0.01 48.80 HYPERVIGILANCE | 1 0.01 48.81 HYPOACUSIS | 3 0.03 48.84 HYPOAESTHESIA | 32 0.32 49.16 HYPOAESTHESIA FACIAL | 3 0.03 49.19 HYPOAESTHESIA ORAL | 4 0.04 49.23 HYPOALBUMINAEMIA | 1 0.01 49.24 HYPOCALCAEMIA | 4 0.04 49.28 HYPOGAMMAGLOBULINAEMIA | 1 0.01 49.29 HYPOGLYCAEMIA | 14 0.14 49.43 HYPOGLYCAEMIC COMA | 1 0.01 49.44 HYPOGLYCAEMIC SEIZURE | 1 0.01 49.45 HYPOGLYCAEMIC UNCONSCIOUSNESS | 3 0.03 49.48 HYPOKALAEMIA | 5 0.05 49.53 HYPOKINESIA | 3 0.03 49.56 HYPOMAGNESAEMIA | 3 0.03 49.59 HYPOMANIA | 1 0.01 49.60 HYPOMENORRHOEA | 1 0.01 49.61 HYPONATRAEMIA | 13 0.13 49.74 HYPOPHAGIA | 4 0.04 49.78 HYPOPHOSPHATAEMIA | 3 0.03 49.81 HYPOSOMNIA | 1 0.01 49.82 HYPOTENSION | 31 0.31 50.13 HYPOTHALAMO-PITUITARY DISORDER | 1 0.01 50.14 HYPOTHERMIA | 3 0.03 50.17 HYPOTHYROIDISM | 6 0.06 50.23 HYPOTONIA | 4 0.04 50.27 HYPOURICAEMIA | 1 0.01 50.28 HYPOVOLAEMIA | 2 0.02 50.30 HYPOXIA | 5 0.05 50.35 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY | 1 0.01 50.36 HYSTERECTOMY | 6 0.06 50.42 IATROGENIC INJURY | 1 0.01 50.43 ICHTHYOSIS | 1 0.01 50.44 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 2 0.02 50.46 IGA NEPHROPATHY | 2 0.02 50.48 ILEITIS | 1 0.01 50.49 ILEUS | 4 0.04 50.53 ILEUS PARALYTIC | 3 0.03 50.56 ILL-DEFINED DISORDER | 1 0.01 50.57 IMMOBILE | 2 0.02 50.59 IMMUNE RECONSTITUTION SYNDROME | 4 0.04 50.63 IMMUNODEFICIENCY | 1 0.01 50.64 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED | 2 0.02 50.66 IMMUNOSUPPRESSION | 3 0.03 50.69 IMPAIRED DRIVING ABILITY | 3 0.03 50.72 IMPAIRED GASTRIC EMPTYING | 2 0.02 50.74 IMPAIRED HEALING | 12 0.12 50.86 IMPAIRED WORK ABILITY | 4 0.04 50.90 IMPLANTABLE DEFIBRILLATOR INSERTION | 1 0.01 50.91 IMPRISONMENT | 1 0.01 50.92 IMPULSE-CONTROL DISORDER | 2 0.02 50.94 IMPULSIVE BEHAVIOUR | 2 0.02 50.96 INADEQUATE ANALGESIA | 14 0.14 51.10 INAPPROPRIATE ANTIDIURETIC HORMONE SE.. | 3 0.03 51.13 INAPPROPRIATE SCHEDULE OF DRUG ADMINI.. | 14 0.14 51.27 INCISION SITE HAEMATOMA | 1 0.01 51.28 INCOHERENT | 1 0.01 51.29 INCONTINENCE | 2 0.02 51.31 INCORRECT DOSE ADMINISTERED | 3 0.03 51.34 INCORRECT DRUG ADMINISTRATION DURATION | 1 0.01 51.35 INCORRECT DRUG DOSAGE FORM ADMINISTERED | 1 0.01 51.36 INCORRECT ROUTE OF DRUG ADMINISTRATION | 2 0.02 51.38 INCORRECT STORAGE OF DRUG | 1 0.01 51.39 INCREASED APPETITE | 4 0.04 51.43 INCREASED BRONCHIAL SECRETION | 2 0.02 51.45 INCREASED TENDENCY TO BRUISE | 4 0.04 51.49 INCREASED UPPER AIRWAY SECRETION | 2 0.02 51.51 INDIFFERENCE | 1 0.01 51.52 INFARCTION | 2 0.02 51.54 INFECTED SKIN ULCER | 1 0.01 51.55 INFECTION | 19 0.19 51.74 INFECTIOUS MONONUCLEOSIS | 1 0.01 51.75 INFERTILITY | 1 0.01 51.76 INFERTILITY FEMALE | 1 0.01 51.77 INFLAMMATION | 6 0.06 51.83 INFLAMMATION OF WOUND | 1 0.01 51.84 INFLAMMATORY BOWEL DISEASE | 4 0.04 51.88 INFLAMMATORY MARKER INCREASED | 1 0.01 51.89 INFLUENZA | 8 0.08 51.97 INFLUENZA LIKE ILLNESS | 23 0.23 52.20 INFUSION RELATED REACTION | 12 0.12 52.32 INFUSION SITE ERYTHEMA | 1 0.01 52.33 INFUSION SITE HAEMATOMA | 1 0.01 52.34 INFUSION SITE PAIN | 4 0.04 52.38 INFUSION SITE SCAR | 1 0.01 52.39 INGUINAL HERNIA | 1 0.01 52.40 INJECTION SITE ABSCESS | 1 0.01 52.41 INJECTION SITE CELLULITIS | 1 0.01 52.42 INJECTION SITE DISCOLOURATION | 1 0.01 52.43 INJECTION SITE DISCOMFORT | 2 0.02 52.45 INJECTION SITE ERYTHEMA | 7 0.07 52.52 INJECTION SITE HAEMATOMA | 7 0.07 52.59 INJECTION SITE HAEMORRHAGE | 5 0.05 52.64 INJECTION SITE INDURATION | 1 0.01 52.65 INJECTION SITE INFECTION | 1 0.01 52.66 INJECTION SITE INFLAMMATION | 1 0.01 52.67 INJECTION SITE IRRITATION | 1 0.01 52.68 INJECTION SITE MASS | 3 0.03 52.71 INJECTION SITE NODULE | 2 0.02 52.73 INJECTION SITE OEDEMA | 1 0.01 52.74 INJECTION SITE PAIN | 14 0.14 52.88 INJECTION SITE PRURITUS | 1 0.01 52.89 INJECTION SITE RASH | 2 0.02 52.91 INJECTION SITE REACTION | 3 0.03 52.94 INJECTION SITE VESICLES | 1 0.01 52.95 INJECTION SITE WARMTH | 1 0.01 52.96 INJURY | 22 0.22 53.18 INJURY ASSOCIATED WITH DEVICE | 1 0.01 53.19 INNER EAR DISORDER | 1 0.01 53.20 INSOMNIA | 38 0.38 53.58 INSULIN-REQUIRING TYPE 2 DIABETES MEL.. | 1 0.01 53.59 INTENTIONAL DRUG MISUSE | 6 0.06 53.65 INTENTIONAL OVERDOSE | 8 0.08 53.73 INTENTIONAL SELF-INJURY | 1 0.01 53.74 INTERMITTENT CLAUDICATION | 2 0.02 53.76 INTERNAL FIXATION OF FRACTURE | 1 0.01 53.77 INTERNAL INJURY | 12 0.12 53.89 INTERNATIONAL NORMALISED RATIO DECREA.. | 1 0.01 53.90 INTERNATIONAL NORMALISED RATIO INCREA.. | 3 0.03 53.93 INTERSTITIAL LUNG DISEASE | 11 0.11 54.04 INTERVERTEBRAL DISC COMPRESSION | 1 0.01 54.05 INTERVERTEBRAL DISC DEGENERATION | 6 0.06 54.11 INTERVERTEBRAL DISC PROTRUSION | 9 0.09 54.20 INTERVERTEBRAL DISC SPACE NARROWING | 1 0.01 54.21 INTESTINAL ANASTOMOSIS COMPLICATION | 1 0.01 54.22 INTESTINAL CONGESTION | 1 0.01 54.23 INTESTINAL DILATATION | 1 0.01 54.24 INTESTINAL FUNCTIONAL DISORDER | 2 0.02 54.26 INTESTINAL HAEMORRHAGE | 1 0.01 54.27 INTESTINAL INFARCTION | 1 0.01 54.28 INTESTINAL ISCHAEMIA | 2 0.02 54.30 INTESTINAL OBSTRUCTION | 3 0.03 54.33 INTESTINAL PERFORATION | 5 0.05 54.38 INTESTINAL RESECTION | 1 0.01 54.39 INTESTINAL STENOSIS | 1 0.01 54.40 INTRA-UTERINE CONTRACEPTIVE DEVICE RE.. | 1 0.01 54.41 INTRA-UTERINE DEATH | 3 0.03 54.44 INTRACRANIAL HYPOTENSION | 3 0.03 54.47 INTRACRANIAL PRESSURE INCREASED | 1 0.01 54.48 INTRADUCTAL PAPILLOMA OF BREAST | 1 0.01 54.49 INTRAMEDULLARY ROD INSERTION | 1 0.01 54.50 INTRAOCULAR LENS IMPLANT | 1 0.01 54.51 INTRAOCULAR PRESSURE INCREASED | 5 0.05 54.56 INTRAVENOUS CATHETER MANAGEMENT | 1 0.01 54.57 IRIS HYPOPIGMENTATION | 1 0.01 54.58 IRITIS | 1 0.01 54.59 IRON DEFICIENCY | 1 0.01 54.60 IRON DEFICIENCY ANAEMIA | 3 0.03 54.63 IRRITABILITY | 9 0.09 54.72 IRRITABLE BOWEL SYNDROME | 5 0.05 54.77 ISCHAEMIC STROKE | 6 0.06 54.83 JAUNDICE | 8 0.08 54.91 JAW DISORDER | 4 0.04 54.95 JAW FRACTURE | 3 0.03 54.98 JAW OPERATION | 6 0.06 55.04 JC VIRUS INFECTION | 1 0.01 55.05 JC VIRUS TEST POSITIVE | 6 0.06 55.11 JOINT ARTHROPLASTY | 1 0.01 55.12 JOINT DESTRUCTION | 2 0.02 55.14 JOINT DISLOCATION | 1 0.01 55.15 JOINT INJURY | 4 0.04 55.19 JOINT RANGE OF MOTION DECREASED | 1 0.01 55.20 JOINT SPRAIN | 2 0.02 55.22 JOINT STIFFNESS | 3 0.03 55.25 JOINT SURGERY | 2 0.02 55.27 JOINT SWELLING | 14 0.14 55.41 KARYOTYPE ANALYSIS ABNORMAL | 1 0.01 55.42 KERATOCONJUNCTIVITIS SICCA | 1 0.01 55.43 KIDNEY FIBROSIS | 1 0.01 55.44 KIDNEY INFECTION | 2 0.02 55.46 KIDNEY TRANSPLANT REJECTION | 3 0.03 55.49 KLEBSIELLA BACTERAEMIA | 1 0.01 55.50 KLEBSIELLA INFECTION | 1 0.01 55.51 KNEE ARTHROPLASTY | 4 0.04 55.55 KNEE OPERATION | 6 0.06 55.61 KYPHOSIS | 3 0.03 55.64 LABORATORY TEST ABNORMAL | 1 0.01 55.65 LABYRINTHITIS | 1 0.01 55.66 LACRIMATION INCREASED | 2 0.02 55.68 LACTIC ACIDOSIS | 3 0.03 55.71 LARGE GRANULAR LYMPHOCYTOSIS | 1 0.01 55.72 LARGE INTESTINAL OBSTRUCTION | 1 0.01 55.73 LARYNGEAL OEDEMA | 1 0.01 55.74 LARYNGITIS | 3 0.03 55.77 LARYNX IRRITATION | 1 0.01 55.78 LASER THERAPY | 1 0.01 55.79 LEARNING DISORDER | 1 0.01 55.80 LEFT VENTRICULAR DYSFUNCTION | 2 0.02 55.82 LEFT VENTRICULAR FAILURE | 2 0.02 55.84 LEG AMPUTATION | 1 0.01 55.85 LETHARGY | 6 0.06 55.91 LEUKAEMIA | 4 0.04 55.95 LEUKAEMIA RECURRENT | 5 0.05 56.00 LEUKOCYTOCLASTIC VASCULITIS | 3 0.03 56.03 LEUKOCYTOSIS | 6 0.06 56.09 LEUKOCYTURIA | 1 0.01 56.10 LEUKOPENIA | 4 0.04 56.14 LEUKOPLAKIA ORAL | 1 0.01 56.15 LHERMITTE'S SIGN | 1 0.01 56.16 LIBIDO DECREASED | 1 0.01 56.17 LIFE EXPECTANCY SHORTENED | 1 0.01 56.18 LIGAMENT OPERATION | 1 0.01 56.19 LIGHT CHAIN ANALYSIS INCREASED | 1 0.01 56.20 LIMB DEFORMITY | 1 0.01 56.21 LIMB DISCOMFORT | 1 0.01 56.22 LIMB INJURY | 3 0.03 56.25 LIMB OPERATION | 1 0.01 56.26 LIMB TRAUMATIC AMPUTATION | 1 0.01 56.27 LIP BLISTER | 3 0.03 56.30 LIP DRY | 4 0.04 56.34 LIP HAEMORRHAGE | 1 0.01 56.35 LIP OEDEMA | 2 0.02 56.37 LIP PAIN | 1 0.01 56.38 LIP SWELLING | 11 0.11 56.49 LIPASE INCREASED | 4 0.04 56.53 LIPID METABOLISM DISORDER | 1 0.01 56.54 LIPIDS DECREASED | 1 0.01 56.55 LIPIDS INCREASED | 1 0.01 56.56 LIPOMA | 1 0.01 56.57 LIVE BIRTH | 1 0.01 56.58 LIVER ABSCESS | 1 0.01 56.59 LIVER DISORDER | 6 0.06 56.65 LIVER FUNCTION TEST ABNORMAL | 6 0.06 56.71 LIVER INJURY | 1 0.01 56.72 LOBAR PNEUMONIA | 1 0.01 56.73 LOCALISED INFECTION | 2 0.02 56.75 LOCALISED OEDEMA | 1 0.01 56.76 LOGORRHOEA | 2 0.02 56.78 LOOSE TOOTH | 2 0.02 56.80 LORDOSIS | 1 0.01 56.81 LOSS OF CONSCIOUSNESS | 27 0.27 57.08 LOSS OF CONTROL OF LEGS | 4 0.04 57.12 LOW DENSITY LIPOPROTEIN INCREASED | 1 0.01 57.13 LOW TURNOVER OSTEOPATHY | 3 0.03 57.16 LOWER GASTROINTESTINAL HAEMORRHAGE | 1 0.01 57.17 LOWER LIMB FRACTURE | 7 0.07 57.24 LUDWIG ANGINA | 1 0.01 57.25 LUMBAR RADICULOPATHY | 2 0.02 57.27 LUNG ABSCESS | 2 0.02 57.29 LUNG CYST | 1 0.01 57.30 LUNG DISORDER | 6 0.06 57.36 LUNG INFECTION | 3 0.03 57.39 LUNG INFILTRATION | 5 0.05 57.44 LUNG NEOPLASM | 1 0.01 57.45 LUNG NEOPLASM MALIGNANT | 6 0.06 57.51 LUNG OPERATION | 1 0.01 57.52 LUNG SQUAMOUS CELL CARCINOMA STAGE UN.. | 2 0.02 57.54 LUNG TRANSPLANT REJECTION | 1 0.01 57.55 LUPUS NEPHRITIS | 1 0.01 57.56 LUPUS-LIKE SYNDROME | 2 0.02 57.58 LYMPH NODE PAIN | 1 0.01 57.59 LYMPHADENOPATHY | 9 0.09 57.68 LYMPHADENOPATHY MEDIASTINAL | 2 0.02 57.70 LYMPHOCYTE COUNT INCREASED | 1 0.01 57.71 LYMPHOCYTIC INFILTRATION | 1 0.01 57.72 LYMPHOCYTIC LYMPHOMA | 1 0.01 57.73 LYMPHOCYTOSIS | 1 0.01 57.74 LYMPHOMA | 4 0.04 57.78 LYMPHOPENIA | 1 0.01 57.79 MACULAR DEGENERATION | 3 0.03 57.82 MACULAR HOLE | 1 0.01 57.83 MACULAR OEDEMA | 1 0.01 57.84 MACULAR SCAR | 1 0.01 57.85 MADAROSIS | 1 0.01 57.86 MAJOR DEPRESSION | 2 0.02 57.88 MALAISE | 72 0.72 58.60 MALIGNANT MELANOMA | 2 0.02 58.62 MALIGNANT MELANOMA STAGE III | 1 0.01 58.63 MALIGNANT NEOPLASM PROGRESSION | 14 0.14 58.77 MALIGNANT PLEURAL EFFUSION | 2 0.02 58.79 MALNUTRITION | 2 0.02 58.81 MAMMARY DUCT ECTASIA | 1 0.01 58.82 MANIA | 2 0.02 58.84 MASS | 3 0.03 58.87 MASTECTOMY | 2 0.02 58.89 MASTICATION DISORDER | 4 0.04 58.93 MASTOIDITIS | 1 0.01 58.94 MATERNAL DRUGS AFFECTING FOETUS | 1 0.01 58.95 MAXILLOFACIAL OPERATION | 1 0.01 58.96 MEAN CELL HAEMOGLOBIN DECREASED | 1 0.01 58.97 MEAN PLATELET VOLUME ABNORMAL | 1 0.01 58.98 MECHANICAL VENTILATION | 3 0.03 59.01 MEDICAL DEVICE PAIN | 1 0.01 59.02 MEDICAL DEVICE REMOVAL | 1 0.01 59.03 MEDICATION ERROR | 7 0.07 59.10 MEDICATION RESIDUE | 3 0.03 59.13 MELAENA | 3 0.03 59.16 MELANOCYTIC NAEVUS | 2 0.02 59.18 MELANOMA RECURRENT | 1 0.01 59.19 MELANOSIS COLI | 1 0.01 59.20 MEMORY IMPAIRMENT | 48 0.48 59.68 MENINGIOMA | 1 0.01 59.69 MENINGIOMA SURGERY | 1 0.01 59.70 MENINGISM | 1 0.01 59.71 MENINGITIS | 1 0.01 59.72 MENINGITIS ASEPTIC | 1 0.01 59.73 MENINGITIS BACTERIAL | 1 0.01 59.74 MENINGITIS VIRAL | 1 0.01 59.75 MENINGOENCEPHALITIS BACTERIAL | 1 0.01 59.76 MENISCUS LESION | 3 0.03 59.79 MENOMETRORRHAGIA | 1 0.01 59.80 MENOPAUSAL SYMPTOMS | 2 0.02 59.82 MENORRHAGIA | 4 0.04 59.86 MENSTRUAL DISORDER | 2 0.02 59.88 MENSTRUATION DELAYED | 3 0.03 59.91 MENSTRUATION IRREGULAR | 1 0.01 59.92 MENTAL DISORDER | 22 0.22 60.14 MENTAL IMPAIRMENT | 7 0.07 60.21 MENTAL STATUS CHANGES | 13 0.13 60.34 MESENTERIC PANNICULITIS | 1 0.01 60.35 MESENTERIC VEIN THROMBOSIS | 1 0.01 60.36 METABOLIC ACIDOSIS | 1 0.01 60.37 METABOLIC DISORDER | 1 0.01 60.38 METAPLASIA | 1 0.01 60.39 METASTASES TO BONE | 8 0.08 60.47 METASTASES TO CENTRAL NERVOUS SYSTEM | 1 0.01 60.48 METASTASES TO LIVER | 2 0.02 60.50 METASTASES TO LUNG | 3 0.03 60.53 METASTASES TO MENINGES | 1 0.01 60.54 METASTASES TO NECK | 1 0.01 60.55 METASTASES TO SPINE | 4 0.04 60.59 METASTASIS | 2 0.02 60.61 METASTATIC NEOPLASM | 3 0.03 60.64 METRORRHAGIA | 2 0.02 60.66 MICROCYTIC ANAEMIA | 1 0.01 60.67 MICTURITION DISORDER | 1 0.01 60.68 MICTURITION URGENCY | 4 0.04 60.72 MIDDLE EAR EFFUSION | 3 0.03 60.75 MIGRAINE | 18 0.18 60.93 MIGRAINE WITH AURA | 1 0.01 60.94 MILIA | 1 0.01 60.95 MIOSIS | 2 0.02 60.97 MITRAL VALVE CALCIFICATION | 1 0.01 60.98 MITRAL VALVE INCOMPETENCE | 2 0.02 61.00 MOBILITY DECREASED | 14 0.14 61.14 MOLLUSCUM CONTAGIOSUM | 1 0.01 61.15 MONOCLONAL GAMMOPATHY | 1 0.01 61.16 MONOCYTE COUNT INCREASED | 1 0.01 61.17 MONONEUROPATHY MULTIPLEX | 1 0.01 61.18 MONOPLEGIA | 1 0.01 61.19 MOOD ALTERED | 7 0.07 61.26 MOOD SWINGS | 6 0.06 61.32 MOTION SICKNESS | 1 0.01 61.33 MOTOR DYSFUNCTION | 3 0.03 61.36 MOUTH BREATHING | 1 0.01 61.37 MOUTH HAEMORRHAGE | 3 0.03 61.40 MOUTH INJURY | 1 0.01 61.41 MOUTH ULCERATION | 2 0.02 61.43 MOVEMENT DISORDER | 2 0.02 61.45 MUCOSAL ULCERATION | 1 0.01 61.46 MUCOUS MEMBRANE DISORDER | 12 0.12 61.58 MULTI-ORGAN DISORDER | 1 0.01 61.59 MULTI-ORGAN FAILURE | 7 0.07 61.66 MULTIPLE ALLERGIES | 2 0.02 61.68 MULTIPLE DRUG OVERDOSE | 1 0.01 61.69 MULTIPLE DRUG OVERDOSE INTENTIONAL | 2 0.02 61.71 MULTIPLE FRACTURES | 3 0.03 61.74 MULTIPLE INJURIES | 5 0.05 61.79 MULTIPLE MYELOMA | 10 0.10 61.89 MULTIPLE SCLEROSIS | 24 0.24 62.13 MULTIPLE SCLEROSIS RELAPSE | 54 0.54 62.67 MUSCLE ATROPHY | 4 0.04 62.71 MUSCLE CONTRACTIONS INVOLUNTARY | 2 0.02 62.73 MUSCLE DISORDER | 4 0.04 62.77 MUSCLE FATIGUE | 3 0.03 62.80 MUSCLE INJURY | 2 0.02 62.82 MUSCLE RUPTURE | 2 0.02 62.84 MUSCLE SPASMS | 24 0.24 63.08 MUSCLE SPASTICITY | 5 0.05 63.13 MUSCLE STRAIN | 5 0.05 63.18 MUSCLE SWELLING | 2 0.02 63.20 MUSCLE TIGHTNESS | 4 0.04 63.24 MUSCLE TWITCHING | 8 0.08 63.32 MUSCULAR WEAKNESS | 40 0.40 63.72 MUSCULOSKELETAL CHEST PAIN | 5 0.05 63.77 MUSCULOSKELETAL DISCOMFORT | 5 0.05 63.82 MUSCULOSKELETAL DISORDER | 11 0.11 63.93 MUSCULOSKELETAL PAIN | 15 0.15 64.08 MUSCULOSKELETAL STIFFNESS | 16 0.16 64.24 MYALGIA | 33 0.33 64.57 MYASTHENIA GRAVIS | 1 0.01 64.58 MYDRIASIS | 1 0.01 64.59 MYELITIS | 1 0.01 64.60 MYELODYSPLASTIC SYNDROME | 4 0.04 64.64 MYELODYSPLASTIC SYNDROME TRANSFORMATION | 1 0.01 64.65 MYELOMA RECURRENCE | 1 0.01 64.66 MYOCARDIAL INFARCTION | 38 0.38 65.04 MYOCARDIAL ISCHAEMIA | 3 0.03 65.07 MYOCLONUS | 2 0.02 65.09 MYOFASCIAL PAIN SYNDROME | 2 0.02 65.11 MYOPATHY | 2 0.02 65.13 MYOSITIS | 3 0.03 65.16 NAIL DISORDER | 12 0.12 65.28 NARCOTIC INTOXICATION | 1 0.01 65.29 NASAL CONGESTION | 4 0.04 65.33 NASAL POLYPS | 1 0.01 65.34 NASAL SEPTUM DEVIATION | 1 0.01 65.35 NASAL SINUS CANCER | 1 0.01 65.36 NASOPHARYNGITIS | 26 0.26 65.62 NAUSEA | 107 1.07 66.69 NECK PAIN | 10 0.10 66.79 NECROSIS | 2 0.02 66.81 NEONATAL ASPIRATION | 1 0.01 66.82 NEONATAL RESPIRATORY DISTRESS SYNDROME | 3 0.03 66.85 NEOPLASM | 1 0.01 66.86 NEOPLASM MALIGNANT | 8 0.08 66.94 NEOPLASM PROSTATE | 1 0.01 66.95 NEPHRECTOMY | 1 0.01 66.96 NEPHRITIS | 1 0.01 66.97 NEPHROLITHIASIS | 13 0.13 67.10 NEPHROPATHY | 2 0.02 67.12 NEPHROSCLEROSIS | 1 0.01 67.13 NERVE COMPRESSION | 2 0.02 67.15 NERVE INJURY | 2 0.02 67.17 NERVOUS SYSTEM DISORDER | 3 0.03 67.20 NERVOUS SYSTEM NEOPLASM | 1 0.01 67.21 NERVOUSNESS | 17 0.17 67.38 NEURALGIA | 7 0.07 67.45 NEURITIS | 1 0.01 67.46 NEUROLEPTIC MALIGNANT SYNDROME | 4 0.04 67.50 NEUROLOGICAL DECOMPENSATION | 1 0.01 67.51 NEUROLOGICAL EXAMINATION ABNORMAL | 1 0.01 67.52 NEUROLOGICAL SYMPTOM | 2 0.02 67.54 NEUROPATHY PERIPHERAL | 20 0.20 67.74 NEUROSIS | 1 0.01 67.75 NEUROTOXICITY | 3 0.03 67.78 NEUTROPENIA | 8 0.08 67.86 NEUTROPENIC SEPSIS | 1 0.01 67.87 NEUTROPHIL COUNT DECREASED | 9 0.09 67.96 NEUTROPHILIA | 1 0.01 67.97 NIGHT BLINDNESS | 1 0.01 67.98 NIGHT SWEATS | 4 0.04 68.02 NIGHTMARE | 4 0.04 68.06 NO ADVERSE EVENT | 8 0.08 68.14 NO THERAPEUTIC RESPONSE | 2 0.02 68.16 NOCTURIA | 4 0.04 68.20 NODULAR VASCULITIS | 1 0.01 68.21 NODULE ON EXTREMITY | 1 0.01 68.22 NON-CARDIAC CHEST PAIN | 1 0.01 68.23 NON-HODGKIN'S LYMPHOMA | 4 0.04 68.27 NONSPECIFIC REACTION | 2 0.02 68.29 NORMAL NEWBORN | 1 0.01 68.30 NOSOCOMIAL INFECTION | 2 0.02 68.32 NUCLEAR MAGNETIC RESONANCE IMAGING AB.. | 2 0.02 68.34 NYSTAGMUS | 2 0.02 68.36 OBESITY | 4 0.04 68.40 OBLITERATIVE BRONCHIOLITIS | 1 0.01 68.41 OBSESSIVE THOUGHTS | 1 0.01 68.42 OBSESSIVE-COMPULSIVE DISORDER | 2 0.02 68.44 OBSTRUCTIVE AIRWAYS DISORDER | 2 0.02 68.46 OBSTRUCTIVE UROPATHY | 1 0.01 68.47 OCCULT BLOOD | 1 0.01 68.48 OCULAR HYPERAEMIA | 3 0.03 68.51 OCULAR ICTERUS | 2 0.02 68.53 OCULOGYRIC CRISIS | 1 0.01 68.54 ODYNOPHAGIA | 1 0.01 68.55 OEDEMA | 8 0.08 68.63 OEDEMA MOUTH | 2 0.02 68.65 OEDEMA PERIPHERAL | 35 0.35 69.00 OESOPHAGEAL HYPOMOTILITY | 1 0.01 69.01 OESOPHAGEAL NEOPLASM | 1 0.01 69.02 OESOPHAGEAL OPERATION | 1 0.01 69.03 OESOPHAGEAL PH | 1 0.01 69.04 OESOPHAGEAL SPASM | 1 0.01 69.05 OESOPHAGEAL STENOSIS | 1 0.01 69.06 OESOPHAGEAL ULCER | 1 0.01 69.07 OESOPHAGEAL ULCER HAEMORRHAGE | 1 0.01 69.08 OESOPHAGITIS | 2 0.02 69.10 OFF LABEL USE | 19 0.19 69.29 OLIGURIA | 1 0.01 69.30 ONYCHOCLASIS | 1 0.01 69.31 ONYCHOMYCOSIS | 2 0.02 69.33 OPEN REDUCTION OF FRACTURE | 1 0.01 69.34 OPERATIVE HAEMORRHAGE | 1 0.01 69.35 OPIATES POSITIVE | 1 0.01 69.36 OPTIC ATROPHY | 1 0.01 69.37 OPTIC ISCHAEMIC NEUROPATHY | 1 0.01 69.38 OPTIC NERVE DISORDER | 1 0.01 69.39 OPTIC NERVE INJURY | 1 0.01 69.40 OPTIC NEURITIS | 3 0.03 69.43 ORAL CANDIDIASIS | 3 0.03 69.46 ORAL CAVITY FISTULA | 1 0.01 69.47 ORAL DISORDER | 6 0.06 69.53 ORAL FUNGAL INFECTION | 1 0.01 69.54 ORAL HERPES | 4 0.04 69.58 ORAL INFECTION | 2 0.02 69.60 ORAL MUCOSAL EXFOLIATION | 2 0.02 69.62 ORAL PAIN | 5 0.05 69.67 ORAL SURGERY | 2 0.02 69.69 ORAL TORUS | 1 0.01 69.70 ORGANIC ERECTILE DYSFUNCTION | 3 0.03 69.73 ORGANISING PNEUMONIA | 1 0.01 69.74 OROANTRAL FISTULA | 1 0.01 69.75 OROMANDIBULAR DYSTONIA | 1 0.01 69.76 OROPHARYNGEAL BLISTERING | 2 0.02 69.78 OROPHARYNGEAL DISCOMFORT | 1 0.01 69.79 OROPHARYNGEAL PAIN | 21 0.21 70.00 OROPHARYNGEAL PLAQUE | 1 0.01 70.01 ORTHOPEDIC PROCEDURE | 1 0.01 70.02 ORTHOPNOEA | 1 0.01 70.03 ORTHOSTATIC HYPOTENSION | 4 0.04 70.07 OSTECTOMY | 1 0.01 70.08 OSTEITIS | 1 0.01 70.09 OSTEITIS DEFORMANS | 2 0.02 70.11 OSTEOARTHRITIS | 14 0.14 70.25 OSTEOLYSIS | 4 0.04 70.29 OSTEOMALACIA | 1 0.01 70.30 OSTEOMYELITIS | 13 0.13 70.43 OSTEONECROSIS | 4 0.04 70.47 OSTEONECROSIS OF JAW | 32 0.32 70.79 OSTEOPENIA | 8 0.08 70.87 OSTEOPOROSIS | 8 0.08 70.95 OVARIAN CANCER | 5 0.05 71.00 OVARIAN CYST | 4 0.04 71.04 OVARIAN CYST RUPTURED | 1 0.01 71.05 OVARIAN MASS | 1 0.01 71.06 OVARIAN TORSION | 1 0.01 71.07 OVERDOSE | 19 0.19 71.26 OVERGROWTH BACTERIAL | 1 0.01 71.27 OXYGEN SATURATION DECREASED | 5 0.05 71.32 OXYGEN SUPPLEMENTATION | 2 0.02 71.34 PAIN | 118 1.18 72.52 PAIN IN EXTREMITY | 68 0.68 73.20 PAIN IN JAW | 14 0.14 73.34 PAIN OF SKIN | 1 0.01 73.35 PALATAL OEDEMA | 2 0.02 73.37 PALLOR | 4 0.04 73.41 PALMAR ERYTHEMA | 1 0.01 73.42 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SY.. | 7 0.07 73.49 PALPITATIONS | 15 0.15 73.64 PANCREATIC CARCINOMA | 2 0.02 73.66 PANCREATIC CARCINOMA METASTATIC | 1 0.01 73.67 PANCREATIC NEOPLASM | 1 0.01 73.68 PANCREATITIS | 18 0.18 73.86 PANCREATITIS ACUTE | 5 0.05 73.91 PANCREATITIS HAEMORRHAGIC | 1 0.01 73.92 PANCYTOPENIA | 13 0.13 74.05 PANIC ATTACK | 8 0.08 74.13 PANIC DISORDER | 3 0.03 74.16 PAPILLOEDEMA | 1 0.01 74.17 PAPILLOMA VIRAL INFECTION | 2 0.02 74.19 PARAESTHESIA | 20 0.20 74.39 PARAESTHESIA ORAL | 4 0.04 74.43 PARALYSIS | 3 0.03 74.46 PARANOIA | 5 0.05 74.51 PARAPARESIS | 1 0.01 74.52 PARAPLEGIA | 2 0.02 74.54 PARATHYROIDECTOMY | 1 0.01 74.55 PARESIS | 2 0.02 74.57 PARKINSON'S DISEASE | 2 0.02 74.59 PARKINSONISM | 3 0.03 74.62 PAROSMIA | 2 0.02 74.64 PAROXYSMAL ARRHYTHMIA | 1 0.01 74.65 PARTIAL SEIZURES | 1 0.01 74.66 PATELLA FRACTURE | 2 0.02 74.68 PATHOLOGICAL FRACTURE | 1 0.01 74.69 PATHOLOGICAL GAMBLING | 2 0.02 74.71 PECTUS EXCAVATUM | 1 0.01 74.72 PELVI-URETERIC OBSTRUCTION | 1 0.01 74.73 PELVIC FRACTURE | 2 0.02 74.75 PELVIC INFLAMMATORY DISEASE | 1 0.01 74.76 PELVIC MASS | 1 0.01 74.77 PELVIC PAIN | 2 0.02 74.79 PEMPHIGUS | 1 0.01 74.80 PENILE PAIN | 1 0.01 74.81 PENIS DISORDER | 2 0.02 74.83 PEPTIC ULCER | 2 0.02 74.85 PERIARTHRITIS | 1 0.01 74.86 PERICARDIAL EFFUSION | 2 0.02 74.88 PERICARDIAL HAEMORRHAGE | 1 0.01 74.89 PERICARDITIS | 3 0.03 74.92 PERICARDITIS ADHESIVE | 1 0.01 74.93 PERINEURIAL CYST | 1 0.01 74.94 PERIODONTITIS | 4 0.04 74.98 PERIORBITAL HAEMATOMA | 1 0.01 74.99 PERIORBITAL OEDEMA | 1 0.01 75.00 PERIPHERAL COLDNESS | 1 0.01 75.01 PERIPHERAL ISCHAEMIA | 3 0.03 75.04 PERIPHERAL NERVE INJURY | 1 0.01 75.05 PERIPHERAL SENSORY NEUROPATHY | 2 0.02 75.07 PERIPHERAL VASCULAR DISORDER | 5 0.05 75.12 PERIPROCTITIS | 3 0.03 75.15 PERIRECTAL ABSCESS | 1 0.01 75.16 PERITONEAL DISORDER | 1 0.01 75.17 PERITONITIS | 2 0.02 75.19 PERITONITIS BACTERIAL | 1 0.01 75.20 PERONEAL NERVE PALSY | 4 0.04 75.24 PERSECUTORY DELUSION | 2 0.02 75.26 PERSONALITY CHANGE | 3 0.03 75.29 PERSONALITY DISORDER | 1 0.01 75.30 PETECHIAE | 1 0.01 75.31 PEYRONIE'S DISEASE | 1 0.01 75.32 PHAEOCHROMOCYTOMA | 1 0.01 75.33 PHARYNGEAL DISORDER | 1 0.01 75.34 PHARYNGEAL OEDEMA | 3 0.03 75.37 PHARYNGITIS | 2 0.02 75.39 PHARYNGITIS STREPTOCOCCAL | 3 0.03 75.42 PHLEBITIS | 1 0.01 75.43 PHOTOPHOBIA | 2 0.02 75.45 PHOTOPSIA | 2 0.02 75.47 PHOTOSENSITIVITY REACTION | 4 0.04 75.51 PHYSICAL ASSAULT | 1 0.01 75.52 PHYSICAL DISABILITY | 2 0.02 75.54 PHYSIOTHERAPY | 1 0.01 75.55 PIGMENTATION DISORDER | 12 0.12 75.67 PILONIDAL CYST CONGENITAL | 1 0.01 75.68 PINEOCYTOMA | 1 0.01 75.69 PIRIFORMIS SYNDROME | 1 0.01 75.70 PITUITARY TUMOUR BENIGN | 1 0.01 75.71 PITUITARY TUMOUR RECURRENT | 1 0.01 75.72 PITUITARY TUMOUR REMOVAL | 1 0.01 75.73 PLANTAR FASCIITIS | 2 0.02 75.75 PLASMACYTOSIS | 2 0.02 75.77 PLATELET COUNT DECREASED | 12 0.12 75.89 PLEURAL EFFUSION | 12 0.12 76.01 PLEURECTOMY | 1 0.01 76.02 PLEURISY | 2 0.02 76.04 PLEURITIC PAIN | 1 0.01 76.05 PNEUMATOSIS INTESTINALIS | 1 0.01 76.06 PNEUMOCYSTIS JIROVECI PNEUMONIA | 1 0.01 76.07 PNEUMOMEDIASTINUM | 1 0.01 76.08 PNEUMONIA | 63 0.63 76.71 PNEUMONIA ASPIRATION | 3 0.03 76.74 PNEUMONIA BACTERIAL | 3 0.03 76.77 PNEUMONIA KLEBSIELLA | 2 0.02 76.79 PNEUMONIA PNEUMOCOCCAL | 1 0.01 76.80 PNEUMONIA PRIMARY ATYPICAL | 1 0.01 76.81 PNEUMONIA STAPHYLOCOCCAL | 1 0.01 76.82 PNEUMONIA VIRAL | 3 0.03 76.85 PNEUMONITIS | 1 0.01 76.86 PNEUMOTHORAX | 1 0.01 76.87 POLLAKIURIA | 8 0.08 76.95 POLYDACTYLY | 1 0.01 76.96 POLYMYALGIA RHEUMATICA | 1 0.01 76.97 POLYNEUROPATHY | 3 0.03 77.00 POLYP | 3 0.03 77.03 POLYP COLORECTAL | 3 0.03 77.06 POLYPECTOMY | 3 0.03 77.09 POLYSEROSITIS | 1 0.01 77.10 POLYURIA | 2 0.02 77.12 POOR DENTAL CONDITION | 1 0.01 77.13 POOR PERIPHERAL CIRCULATION | 2 0.02 77.15 POOR PERSONAL HYGIENE | 2 0.02 77.17 POOR QUALITY DRUG ADMINISTERED | 1 0.01 77.18 POOR QUALITY SLEEP | 1 0.01 77.19 POOR VENOUS ACCESS | 8 0.08 77.27 PORTAL VEIN THROMBOSIS | 1 0.01 77.28 PORTAL VENOUS GAS | 1 0.01 77.29 POST CHOLECYSTECTOMY SYNDROME | 1 0.01 77.30 POST PROCEDURAL COMPLICATION | 1 0.01 77.31 POST PROCEDURAL DISCOMFORT | 1 0.01 77.32 POST PROCEDURAL HAEMORRHAGE | 3 0.03 77.35 POST PROCEDURAL INFECTION | 1 0.01 77.36 POST PROCEDURAL SWELLING | 1 0.01 77.37 POSTICTAL STATE | 1 0.01 77.38 POSTMENOPAUSE | 1 0.01 77.39 POSTOPERATIVE ABSCESS | 1 0.01 77.40 POSTOPERATIVE ILEUS | 2 0.02 77.42 POSTOPERATIVE WOUND INFECTION | 2 0.02 77.44 POSTPARTUM HAEMORRHAGE | 2 0.02 77.46 PRE-ECLAMPSIA | 1 0.01 77.47 PRECANCEROUS CELLS PRESENT | 1 0.01 77.48 PRECANCEROUS SKIN LESION | 1 0.01 77.49 PREGNANCY | 10 0.10 77.59 PREGNANCY ON ORAL CONTRACEPTIVE | 4 0.04 77.63 PREGNANCY WITH CONTRACEPTIVE DEVICE | 7 0.07 77.70 PREMATURE BABY | 3 0.03 77.73 PREMATURE LABOUR | 1 0.01 77.74 PREMATURE RUPTURE OF MEMBRANES | 1 0.01 77.75 PREMENSTRUAL SYNDROME | 1 0.01 77.76 PRESYNCOPE | 7 0.07 77.83 PRIAPISM | 2 0.02 77.85 PRIMARY HYPERALDOSTERONISM | 2 0.02 77.87 PRIMARY SEQUESTRUM | 1 0.01 77.88 PROCEDURAL COMPLICATION | 1 0.01 77.89 PROCEDURAL PAIN | 4 0.04 77.93 PROCTITIS | 1 0.01 77.94 PROCTOCOLITIS | 1 0.01 77.95 PRODUCT ADHESION ISSUE | 9 0.09 78.04 PRODUCT COUNTERFEIT | 2 0.02 78.06 PRODUCT LABEL ON WRONG PRODUCT | 1 0.01 78.07 PRODUCT PACKAGING ISSUE | 1 0.01 78.08 PRODUCT QUALITY ISSUE | 45 0.45 78.53 PRODUCT SIZE ISSUE | 1 0.01 78.54 PRODUCTIVE COUGH | 1 0.01 78.55 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALO.. | 7 0.07 78.62 PROLONGED EXPIRATION | 1 0.01 78.63 PROSTATE CANCER | 3 0.03 78.66 PROSTATE CANCER STAGE IV | 1 0.01 78.67 PROSTATE INFECTION | 1 0.01 78.68 PROSTATECTOMY | 1 0.01 78.69 PROSTATIC SPECIFIC ANTIGEN INCREASED | 3 0.03 78.72 PROSTATOMEGALY | 1 0.01 78.73 PROTEIN TOTAL DECREASED | 1 0.01 78.74 PROTEINURIA | 2 0.02 78.76 PROTHROMBIN LEVEL DECREASED | 2 0.02 78.78 PROTHROMBIN TIME PROLONGED | 1 0.01 78.79 PRURITUS | 46 0.46 79.25 PRURITUS GENERALISED | 6 0.06 79.31 PSEUDOLYMPHOMA | 1 0.01 79.32 PSEUDOMONAL SEPSIS | 2 0.02 79.34 PSEUDOMONAS INFECTION | 2 0.02 79.36 PSORIASIS | 4 0.04 79.40 PSORIATIC ARTHROPATHY | 1 0.01 79.41 PSYCHIATRIC SYMPTOM | 1 0.01 79.42 PSYCHOMOTOR HYPERACTIVITY | 2 0.02 79.44 PSYCHOMOTOR RETARDATION | 1 0.01 79.45 PSYCHOTIC BEHAVIOUR | 1 0.01 79.46 PSYCHOTIC DISORDER | 9 0.09 79.55 PUBIS FRACTURE | 1 0.01 79.56 PULMONARY AIR LEAKAGE | 1 0.01 79.57 PULMONARY ARTERIAL WEDGE PRESSURE ABN.. | 1 0.01 79.58 PULMONARY ARTERY ATRESIA | 1 0.01 79.59 PULMONARY ARTERY THERAPEUTIC PROCEDURE | 1 0.01 79.60 PULMONARY ARTERY THROMBOSIS | 1 0.01 79.61 PULMONARY CONGESTION | 2 0.02 79.63 PULMONARY EMBOLISM | 32 0.32 79.95 PULMONARY FIBROSIS | 1 0.01 79.96 PULMONARY HAEMORRHAGE | 2 0.02 79.98 PULMONARY HYPERTENSION | 7 0.07 80.05 PULMONARY INFARCTION | 3 0.03 80.08 PULMONARY MASS | 1 0.01 80.09 PULMONARY OEDEMA | 9 0.09 80.18 PULMONARY THROMBOSIS | 2 0.02 80.20 PULMONARY TOXICITY | 2 0.02 80.22 PULMONARY TUBERCULOSIS | 2 0.02 80.24 PULPITIS DENTAL | 1 0.01 80.25 PULSE ABSENT | 1 0.01 80.26 PURPURA | 2 0.02 80.28 PURULENT DISCHARGE | 2 0.02 80.30 PUSTULAR PSORIASIS | 1 0.01 80.31 PYELONEPHRITIS | 4 0.04 80.35 PYELONEPHRITIS ACUTE | 1 0.01 80.36 PYODERMA GANGRENOSUM | 1 0.01 80.37 PYOTHORAX | 1 0.01 80.38 PYREXIA | 69 0.69 81.07 RADIAL NERVE PALSY | 1 0.01 81.08 RADICAL HYSTERECTOMY | 1 0.01 81.09 RADICULOPATHY | 1 0.01 81.10 RADIOTHERAPY | 1 0.01 81.11 RADIUS FRACTURE | 1 0.01 81.12 RASH | 41 0.41 81.53 RASH ERYTHEMATOUS | 2 0.02 81.55 RASH GENERALISED | 4 0.04 81.59 RASH MACULAR | 3 0.03 81.62 RASH MACULO-PAPULAR | 4 0.04 81.66 RASH MORBILLIFORM | 2 0.02 81.68 RASH PAPULAR | 2 0.02 81.70 RASH PRURITIC | 4 0.04 81.74 RASH PUSTULAR | 2 0.02 81.76 RASH SCARLATINIFORM | 1 0.01 81.77 RASH VESICULAR | 1 0.01 81.78 RAYNAUD'S PHENOMENON | 1 0.01 81.79 READING DISORDER | 1 0.01 81.80 REBOUND EFFECT | 1 0.01 81.81 RECTAL ABSCESS | 1 0.01 81.82 RECTAL CANCER | 1 0.01 81.83 RECTAL CANCER METASTATIC | 1 0.01 81.84 RECTAL CANCER STAGE I | 1 0.01 81.85 RECTAL HAEMORRHAGE | 4 0.04 81.89 RECTAL POLYP | 1 0.01 81.90 RECTAL ULCER | 1 0.01 81.91 RECURRENT CANCER | 1 0.01 81.92 RED BLOOD CELL COUNT DECREASED | 2 0.02 81.94 RED BLOOD CELL SEDIMENTATION RATE INC.. | 2 0.02 81.96 RED CELL DISTRIBUTION WIDTH INCREASED | 1 0.01 81.97 REFUSAL OF TREATMENT BY PATIENT | 2 0.02 81.99 RENAL ANEURYSM | 1 0.01 82.00 RENAL ARTERY STENOSIS | 1 0.01 82.01 RENAL ARTERY THROMBOSIS | 1 0.01 82.02 RENAL ATROPHY | 3 0.03 82.05 RENAL CANCER | 2 0.02 82.07 RENAL CELL CARCINOMA | 3 0.03 82.10 RENAL COLIC | 1 0.01 82.11 RENAL CYST | 1 0.01 82.12 RENAL DISORDER | 9 0.09 82.21 RENAL FAILURE | 29 0.29 82.50 RENAL FAILURE ACUTE | 19 0.19 82.69 RENAL FAILURE CHRONIC | 5 0.05 82.74 RENAL FUNCTION TEST ABNORMAL | 1 0.01 82.75 RENAL IMPAIRMENT | 15 0.15 82.90 RENAL INJURY | 4 0.04 82.94 RENAL MASS | 2 0.02 82.96 RENAL PAIN | 3 0.03 82.99 RENAL TRANSPLANT | 2 0.02 83.01 RENAL TUBULAR NECROSIS | 1 0.01 83.02 RESPIRATORY ACIDOSIS | 4 0.04 83.06 RESPIRATORY ARREST | 3 0.03 83.09 RESPIRATORY DEPRESSION | 1 0.01 83.10 RESPIRATORY DISORDER | 6 0.06 83.16 RESPIRATORY DISTRESS | 9 0.09 83.25 RESPIRATORY FAILURE | 11 0.11 83.36 RESPIRATORY RATE | 1 0.01 83.37 RESPIRATORY SYNCYTIAL VIRUS BRONCHIOL.. | 1 0.01 83.38 RESPIRATORY SYNCYTIAL VIRUS INFECTION | 1 0.01 83.39 RESPIRATORY TRACT HAEMORRHAGE | 1 0.01 83.40 RESPIRATORY TRACT INFECTION | 6 0.06 83.46 RESTLESS LEGS SYNDROME | 2 0.02 83.48 RESTLESSNESS | 5 0.05 83.53 RETAINED PLACENTA OR MEMBRANES | 1 0.01 83.54 RETCHING | 3 0.03 83.57 RETINAL DETACHMENT | 5 0.05 83.62 RETINAL DISORDER | 1 0.01 83.63 RETINAL HAEMORRHAGE | 5 0.05 83.68 RETINAL PIGMENT EPITHELIAL TEAR | 1 0.01 83.69 RETINAL TEAR | 3 0.03 83.72 RETINAL VASCULAR DISORDER | 1 0.01 83.73 RETINAL VEIN OCCLUSION | 1 0.01 83.74 RETINAL VEIN THROMBOSIS | 1 0.01 83.75 RETINOPATHY | 1 0.01 83.76 RETROGRADE AMNESIA | 1 0.01 83.77 RETROPERITONEAL HAEMORRHAGE | 1 0.01 83.78 RETROPERITONEAL LYMPHADENOPATHY | 1 0.01 83.79 REVERSIBLE POSTERIOR LEUKOENCEPHALOPA.. | 2 0.02 83.81 RHABDOMYOLYSIS | 9 0.09 83.90 RHEUMATOID ARTHRITIS | 12 0.12 84.02 RHINITIS | 3 0.03 84.05 RHINITIS ALLERGIC | 1 0.01 84.06 RHINORRHOEA | 3 0.03 84.09 RHYTHM IDIOVENTRICULAR | 1 0.01 84.10 RIB FRACTURE | 8 0.08 84.18 ROAD TRAFFIC ACCIDENT | 12 0.12 84.30 ROTATOR CUFF SYNDROME | 9 0.09 84.39 ROTAVIRUS INFECTION | 1 0.01 84.40 SACROILIITIS | 1 0.01 84.41 SALIVARY GLAND CANCER | 1 0.01 84.42 SALIVARY HYPERSECRETION | 2 0.02 84.44 SCAB | 2 0.02 84.46 SCAPULA FRACTURE | 1 0.01 84.47 SCAR | 17 0.17 84.64 SCHIZOPHRENIA | 1 0.01 84.65 SCIATIC NERVE INJURY | 1 0.01 84.66 SCIATICA | 5 0.05 84.71 SCLERAL DISCOLOURATION | 1 0.01 84.72 SCOLIOSIS | 3 0.03 84.75 SCREAMING | 1 0.01 84.76 SEBORRHOEA | 2 0.02 84.78 SECONDARY ADRENOCORTICAL INSUFFICIENCY | 1 0.01 84.79 SECONDARY PROGRESSIVE MULTIPLE SCLERO.. | 1 0.01 84.80 SEDATION | 5 0.05 84.85 SELF INJURIOUS BEHAVIOUR | 4 0.04 84.89 SELF-INJURIOUS IDEATION | 1 0.01 84.90 SEMEN ANALYSIS ABNORMAL | 1 0.01 84.91 SEMEN VOLUME DECREASED | 1 0.01 84.92 SENSATION OF HEAVINESS | 2 0.02 84.94 SENSATION OF PRESSURE | 4 0.04 84.98 SENSE OF OPPRESSION | 1 0.01 84.99 SENSITIVITY OF TEETH | 6 0.06 85.05 SENSORY DISTURBANCE | 2 0.02 85.07 SENSORY LOSS | 2 0.02 85.09 SEPSIS | 31 0.31 85.40 SEPTIC SHOCK | 8 0.08 85.48 SEROTONIN SYNDROME | 2 0.02 85.50 SERUM FERRITIN DECREASED | 1 0.01 85.51 SERUM SEROTONIN INCREASED | 1 0.01 85.52 SERUM SICKNESS | 1 0.01 85.53 SEXUAL DYSFUNCTION | 2 0.02 85.55 SHOCK | 1 0.01 85.56 SHOCK HYPOGLYCAEMIC | 1 0.01 85.57 SHOULDER DYSTOCIA | 1 0.01 85.58 SHUNT OCCLUSION | 1 0.01 85.59 SICK SINUS SYNDROME | 1 0.01 85.60 SILENT MYOCARDIAL INFARCTION | 1 0.01 85.61 SIMPLE PARTIAL SEIZURES | 1 0.01 85.62 SINUS BRADYCARDIA | 4 0.04 85.66 SINUS CONGESTION | 2 0.02 85.68 SINUS DISORDER | 3 0.03 85.71 SINUS HEADACHE | 1 0.01 85.72 SINUS OPERATION | 1 0.01 85.73 SINUS POLYP | 2 0.02 85.75 SINUS TACHYCARDIA | 5 0.05 85.80 SINUSITIS | 17 0.17 85.97 SJOGREN'S SYNDROME | 1 0.01 85.98 SKELETAL INJURY | 3 0.03 86.01 SKIN ATROPHY | 1 0.01 86.02 SKIN BURNING SENSATION | 11 0.11 86.13 SKIN CANCER | 4 0.04 86.17 SKIN DISCOLOURATION | 18 0.18 86.35 SKIN DISORDER | 4 0.04 86.39 SKIN EXFOLIATION | 22 0.22 86.61 SKIN FISSURES | 2 0.02 86.63 SKIN FRAGILITY | 1 0.01 86.64 SKIN GRAFT | 1 0.01 86.65 SKIN HYPERPIGMENTATION | 1 0.01 86.66 SKIN INFECTION | 1 0.01 86.67 SKIN INJURY | 1 0.01 86.68 SKIN IRRITATION | 1 0.01 86.69 SKIN LACERATION | 4 0.04 86.73 SKIN LESION | 18 0.18 86.91 SKIN NECROSIS | 1 0.01 86.92 SKIN NEOPLASM EXCISION | 1 0.01 86.93 SKIN ODOUR ABNORMAL | 1 0.01 86.94 SKIN PAPILLOMA | 2 0.02 86.96 SKIN REACTION | 2 0.02 86.98 SKIN SWELLING | 1 0.01 86.99 SKIN TIGHTNESS | 1 0.01 87.00 SKIN TOXICITY | 1 0.01 87.01 SKIN ULCER | 1 0.01 87.02 SKIN WARM | 4 0.04 87.06 SLEEP APNOEA SYNDROME | 8 0.08 87.14 SLEEP ATTACKS | 1 0.01 87.15 SLEEP DISORDER | 11 0.11 87.26 SLEEP TALKING | 1 0.01 87.27 SMALL CELL LUNG CANCER EXTENSIVE STAGE | 1 0.01 87.28 SMALL INTESTINAL OBSTRUCTION | 2 0.02 87.30 SMALL INTESTINAL STENOSIS | 1 0.01 87.31 SMEAR CERVIX ABNORMAL | 1 0.01 87.32 SNEEZING | 1 0.01 87.33 SOCIAL AVOIDANT BEHAVIOUR | 1 0.01 87.34 SOFT TISSUE DISORDER | 2 0.02 87.36 SOFT TISSUE INFECTION | 1 0.01 87.37 SOMNAMBULISM | 3 0.03 87.40 SOMNOLENCE | 20 0.20 87.60 SOPOR | 2 0.02 87.62 SPEECH DISORDER | 12 0.12 87.74 SPEECH REHABILITATION | 1 0.01 87.75 SPERM COUNT DECREASED | 1 0.01 87.76 SPINAL COLUMN STENOSIS | 4 0.04 87.80 SPINAL COMPRESSION FRACTURE | 3 0.03 87.83 SPINAL CORD COMPRESSION | 1 0.01 87.84 SPINAL DEFORMITY | 2 0.02 87.86 SPINAL DISORDER | 1 0.01 87.87 SPINAL FRACTURE | 3 0.03 87.90 SPINAL FUSION ACQUIRED | 1 0.01 87.91 SPINAL FUSION SURGERY | 2 0.02 87.93 SPINAL OSTEOARTHRITIS | 4 0.04 87.97 SPLEEN DISORDER | 1 0.01 87.98 SPLENECTOMY | 1 0.01 87.99 SPLENIC RUPTURE | 1 0.01 88.00 SPLENOMEGALY | 1 0.01 88.01 SPONDYLOLISTHESIS | 4 0.04 88.05 SPUTUM DISCOLOURED | 2 0.02 88.07 SQUAMOUS CELL CARCINOMA | 2 0.02 88.09 STAPHYLOCOCCAL INFECTION | 12 0.12 88.21 STAPHYLOCOCCAL SCALDED SKIN SYNDROME | 1 0.01 88.22 STAPHYLOCOCCAL SEPSIS | 2 0.02 88.24 STATUS EPILEPTICUS | 1 0.01 88.25 STEM CELL TRANSPLANT | 3 0.03 88.28 STENT PLACEMENT | 2 0.02 88.30 STERNAL FRACTURE | 1 0.01 88.31 STEVENS-JOHNSON SYNDROME | 21 0.21 88.52 STILLBIRTH | 2 0.02 88.54 STOMATITIS | 7 0.07 88.61 STRABISMUS | 1 0.01 88.62 STREPTOCOCCUS TEST POSITIVE | 1 0.01 88.63 STRESS | 35 0.35 88.98 STRESS CARDIOMYOPATHY | 1 0.01 88.99 STRESS FRACTURE | 1 0.01 89.00 STRIDOR | 1 0.01 89.01 SUBARACHNOID HAEMORRHAGE | 3 0.03 89.04 SUBCUTANEOUS EMPHYSEMA | 1 0.01 89.05 SUBCUTANEOUS NODULE | 2 0.02 89.07 SUBDURAL HAEMATOMA | 1 0.01 89.08 SUDDEN DEATH | 2 0.02 89.10 SUDDEN ONSET OF SLEEP | 2 0.02 89.12 SUICIDAL IDEATION | 24 0.24 89.36 SUICIDE ATTEMPT | 10 0.10 89.46 SUPRAVALVULAR AORTIC STENOSIS | 1 0.01 89.47 SUPRAVENTRICULAR EXTRASYSTOLES | 1 0.01 89.48 SUPRAVENTRICULAR TACHYCARDIA | 1 0.01 89.49 SURGERY | 20 0.20 89.69 SUSPICIOUSNESS | 1 0.01 89.70 SUTURE INSERTION | 1 0.01 89.71 SWELLING | 27 0.27 89.98 SWELLING FACE | 11 0.11 90.09 SWOLLEN TONGUE | 3 0.03 90.12 SYNCOPE | 18 0.18 90.30 SYNOVIAL CYST | 1 0.01 90.31 SYNOVIAL RUPTURE | 1 0.01 90.32 SYNOVITIS | 1 0.01 90.33 SYPHILIS | 1 0.01 90.34 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME | 1 0.01 90.35 SYSTEMIC LUPUS ERYTHEMATOSUS | 4 0.04 90.39 TACHYARRHYTHMIA | 2 0.02 90.41 TACHYCARDIA | 16 0.16 90.57 TACHYPNOEA | 2 0.02 90.59 TALIPES | 1 0.01 90.60 TARDIVE DYSKINESIA | 1 0.01 90.61 TEMPERATURE INTOLERANCE | 5 0.05 90.66 TEMPOROMANDIBULAR JOINT SURGERY | 1 0.01 90.67 TEMPOROMANDIBULAR JOINT SYNDROME | 2 0.02 90.69 TENDERNESS | 1 0.01 90.70 TENDON DISORDER | 3 0.03 90.73 TENDON PAIN | 1 0.01 90.74 TENDON RUPTURE | 7 0.07 90.81 TENDONITIS | 4 0.04 90.85 TENOSYNOVITIS | 4 0.04 90.89 TENSION | 2 0.02 90.91 TENSION HEADACHE | 2 0.02 90.93 TESTICULAR ATROPHY | 1 0.01 90.94 TESTICULAR DISORDER | 1 0.01 90.95 TETANY | 1 0.01 90.96 THALASSAEMIA | 1 0.01 90.97 THEFT | 1 0.01 90.98 THERAPEUTIC AGENT TOXICITY | 2 0.02 91.00 THERAPEUTIC RESPONSE DECREASED | 10 0.10 91.10 THERAPEUTIC RESPONSE UNEXPECTED | 3 0.03 91.13 THERAPY NAIVE | 1 0.01 91.14 THERMAL BURN | 2 0.02 91.16 THINKING ABNORMAL | 3 0.03 91.19 THIRST | 3 0.03 91.22 THROAT IRRITATION | 6 0.06 91.28 THROAT TIGHTNESS | 1 0.01 91.29 THROMBOCYTOPENIA | 19 0.19 91.48 THROMBOCYTOPENIC PURPURA | 1 0.01 91.49 THROMBOCYTOSIS | 2 0.02 91.51 THROMBOEMBOLECTOMY | 1 0.01 91.52 THROMBOLYSIS | 1 0.01 91.53 THROMBOPHLEBITIS SUPERFICIAL | 1 0.01 91.54 THROMBOSIS | 15 0.15 91.69 THROMBOTIC MICROANGIOPATHY | 1 0.01 91.70 THYMIC CANCER METASTATIC | 1 0.01 91.71 THYROID CANCER | 3 0.03 91.74 THYROID CYST | 1 0.01 91.75 THYROID DISORDER | 6 0.06 91.81 THYROID MASS | 1 0.01 91.82 THYROID NEOPLASM | 3 0.03 91.85 THYROIDECTOMY | 3 0.03 91.88 THYROIDITIS | 2 0.02 91.90 THYROIDITIS SUBACUTE | 1 0.01 91.91 TIBIA FRACTURE | 1 0.01 91.92 TINEA PEDIS | 1 0.01 91.93 TINNITUS | 4 0.04 91.97 TOBACCO WITHDRAWAL SYMPTOMS | 1 0.01 91.98 TONGUE BLISTERING | 1 0.01 91.99 TONGUE DISCOLOURATION | 1 0.01 92.00 TONGUE DISORDER | 2 0.02 92.02 TONGUE EXFOLIATION | 1 0.01 92.03 TONSILLECTOMY | 1 0.01 92.04 TOOTH ABSCESS | 7 0.07 92.11 TOOTH DEPOSIT | 1 0.01 92.12 TOOTH DISCOLOURATION | 2 0.02 92.14 TOOTH DISORDER | 12 0.12 92.26 TOOTH EROSION | 1 0.01 92.27 TOOTH EXTRACTION | 14 0.14 92.41 TOOTH FRACTURE | 5 0.05 92.46 TOOTH INFECTION | 3 0.03 92.49 TOOTH LOSS | 7 0.07 92.56 TOOTH RESORPTION | 1 0.01 92.57 TOOTHACHE | 10 0.10 92.67 TORSADE DE POINTES | 3 0.03 92.70 TORTICOLLIS | 2 0.02 92.72 TOXIC EPIDERMAL NECROLYSIS | 15 0.15 92.87 TOXIC NODULAR GOITRE | 1 0.01 92.88 TOXIC SKIN ERUPTION | 5 0.05 92.93 TOXOPLASMOSIS | 1 0.01 92.94 TRACHEOSTOMY | 1 0.01 92.95 TRACHEOSTOMY MALFUNCTION | 1 0.01 92.96 TRANSAMINASES INCREASED | 5 0.05 93.01 TRANSFUSION | 1 0.01 93.02 TRANSFUSION-RELATED ACUTE LUNG INJURY | 1 0.01 93.03 TRANSIENT GLOBAL AMNESIA | 1 0.01 93.04 TRANSIENT ISCHAEMIC ATTACK | 14 0.14 93.18 TRANSMISSION OF AN INFECTIOUS AGENT V.. | 1 0.01 93.19 TRANSPLANT FAILURE | 1 0.01 93.20 TRANSURETHRAL PROSTATECTOMY | 2 0.02 93.22 TRAUMATIC HAEMATOMA | 1 0.01 93.23 TREATMENT FAILURE | 1 0.01 93.24 TREATMENT NONCOMPLIANCE | 7 0.07 93.31 TREMOR | 36 0.36 93.67 TRICUSPID VALVE INCOMPETENCE | 1 0.01 93.68 TRIGEMINAL NEURALGIA | 1 0.01 93.69 TRIGGER FINGER | 1 0.01 93.70 TRISMUS | 3 0.03 93.73 TRISOMY 21 | 1 0.01 93.74 TROPONIN | 1 0.01 93.75 TUBERCULIN TEST POSITIVE | 1 0.01 93.76 TUBERCULOSIS | 1 0.01 93.77 TUBERCULOUS PLEURISY | 1 0.01 93.78 TUBULOINTERSTITIAL NEPHRITIS | 2 0.02 93.80 TUMOUR EXCISION | 1 0.01 93.81 TYPE 1 DIABETES MELLITUS | 3 0.03 93.84 TYPE 2 DIABETES MELLITUS | 15 0.15 93.99 ULCER | 1 0.01 94.00 ULCER HAEMORRHAGE | 1 0.01 94.01 UMBILICAL HERNIA | 2 0.02 94.03 UNEVALUABLE EVENT | 4 0.04 94.07 UNRESPONSIVE TO STIMULI | 4 0.04 94.11 UPPER GASTROINTESTINAL HAEMORRHAGE | 1 0.01 94.12 UPPER LIMB FRACTURE | 5 0.05 94.17 UPPER RESPIRATORY TRACT INFECTION | 9 0.09 94.26 URETHRAL STENOSIS | 1 0.01 94.27 URINARY INCONTINENCE | 7 0.07 94.34 URINARY RETENTION | 11 0.11 94.45 URINARY TRACT DISORDER | 1 0.01 94.46 URINARY TRACT INFECTION | 38 0.38 94.84 URINARY TRACT INFECTION BACTERIAL | 1 0.01 94.85 URINARY TRACT OBSTRUCTION | 1 0.01 94.86 URINE ABNORMALITY | 1 0.01 94.87 URINE ANALYSIS ABNORMAL | 2 0.02 94.89 URINE CALCIUM INCREASED | 1 0.01 94.90 URINE COLOUR ABNORMAL | 1 0.01 94.91 URINE OUTPUT DECREASED | 3 0.03 94.94 URINE OUTPUT INCREASED | 1 0.01 94.95 UROSEPSIS | 3 0.03 94.98 URTICARIA | 34 0.34 95.32 UTERINE CANCER | 2 0.02 95.34 UTERINE CERVICAL PAIN | 1 0.01 95.35 UTERINE CYST | 2 0.02 95.37 UTERINE DISORDER | 1 0.01 95.38 UTERINE ENLARGEMENT | 1 0.01 95.39 UTERINE LEIOMYOMA | 3 0.03 95.42 UTERINE MASS | 1 0.01 95.43 UTERINE PERFORATION | 5 0.05 95.48 UTERINE POLYP | 1 0.01 95.49 UVEITIS | 1 0.01 95.50 VAGINAL HAEMORRHAGE | 10 0.10 95.60 VAGINAL INFECTION | 2 0.02 95.62 VAGINAL ODOUR | 1 0.01 95.63 VAGINITIS BACTERIAL | 1 0.01 95.64 VARICELLA | 1 0.01 95.65 VARICES OESOPHAGEAL | 2 0.02 95.67 VARICOSE VEIN | 2 0.02 95.69 VARICOSE VEIN OPERATION | 1 0.01 95.70 VASCULAR CALCIFICATION | 1 0.01 95.71 VASCULAR DEMENTIA | 1 0.01 95.72 VASCULAR INSUFFICIENCY | 1 0.01 95.73 VASCULAR OPERATION | 1 0.01 95.74 VASCULAR PSEUDOANEURYSM | 1 0.01 95.75 VASCULITIC RASH | 1 0.01 95.76 VASCULITIS | 3 0.03 95.79 VASOCONSTRICTION | 1 0.01 95.80 VASODILATATION | 1 0.01 95.81 VEIN DISORDER | 4 0.04 95.85 VENA CAVA THROMBOSIS | 1 0.01 95.86 VENOOCCLUSIVE LIVER DISEASE | 1 0.01 95.87 VENOUS INSUFFICIENCY | 2 0.02 95.89 VENOUS OCCLUSION | 1 0.01 95.90 VENOUS PRESSURE INCREASED | 1 0.01 95.91 VENOUS THROMBOSIS | 1 0.01 95.92 VENTRICULAR EXTRASYSTOLES | 6 0.06 95.98 VENTRICULAR FIBRILLATION | 5 0.05 96.03 VENTRICULAR HYPOKINESIA | 2 0.02 96.05 VENTRICULAR HYPOPLASIA | 1 0.01 96.06 VENTRICULAR SEPTAL DEFECT | 1 0.01 96.07 VENTRICULAR TACHYCARDIA | 6 0.06 96.13 VERTEBRAL WEDGING | 1 0.01 96.14 VERTEBROPLASTY | 3 0.03 96.17 VERTIGO | 15 0.15 96.32 VESICOURETERAL REFLUX SURGERY | 1 0.01 96.33 VESICOURETERIC REFLUX | 1 0.01 96.34 VESSEL PUNCTURE SITE HAEMORRHAGE | 1 0.01 96.35 VESTIBULAR DISORDER | 1 0.01 96.36 VIITH NERVE PARALYSIS | 9 0.09 96.45 VIOLENCE-RELATED SYMPTOM | 2 0.02 96.47 VIRAL HEPATITIS CARRIER | 1 0.01 96.48 VIRAL INFECTION | 6 0.06 96.54 VIRAL MYOCARDITIS | 1 0.01 96.55 VIRAL RASH | 1 0.01 96.56 VIRAL TONSILLITIS | 1 0.01 96.57 VISION BLURRED | 30 0.30 96.87 VISUAL ACUITY REDUCED | 11 0.11 96.98 VISUAL FIELD DEFECT | 4 0.04 97.02 VISUAL IMPAIRMENT | 18 0.18 97.20 VITAMIN B12 DECREASED | 3 0.03 97.23 VITAMIN B12 DEFICIENCY | 2 0.02 97.25 VITAMIN D ABNORMAL | 1 0.01 97.26 VITAMIN D DECREASED | 4 0.04 97.30 VITAMIN D DEFICIENCY | 2 0.02 97.32 VITH NERVE PARALYSIS | 1 0.01 97.33 VITREOUS DETACHMENT | 2 0.02 97.35 VITREOUS FLOATERS | 3 0.03 97.38 VITREOUS HAEMORRHAGE | 2 0.02 97.40 VOMITING | 76 0.76 98.16 VULVOVAGINAL BURNING SENSATION | 1 0.01 98.17 VULVOVAGINAL CANDIDIASIS | 1 0.01 98.18 VULVOVAGINAL DRYNESS | 2 0.02 98.20 VULVOVAGINAL MYCOTIC INFECTION | 2 0.02 98.22 VULVOVAGINAL PRURITUS | 1 0.01 98.23 WALKING AID USER | 1 0.01 98.24 WEIGHT ABNORMAL | 1 0.01 98.25 WEIGHT BEARING DIFFICULTY | 1 0.01 98.26 WEIGHT DECREASED | 51 0.51 98.77 WEIGHT FLUCTUATION | 1 0.01 98.78 WEIGHT GAIN POOR | 1 0.01 98.79 WEIGHT INCREASED | 28 0.28 99.07 WHEELCHAIR USER | 1 0.01 99.08 WHEEZING | 5 0.05 99.13 WHITE BLOOD CELL COUNT DECREASED | 17 0.17 99.30 WHITE BLOOD CELL COUNT INCREASED | 6 0.06 99.36 WITHDRAWAL SYNDROME | 14 0.14 99.50 WOUND | 3 0.03 99.53 WOUND DEHISCENCE | 1 0.01 99.54 WOUND DRAINAGE | 2 0.02 99.56 WOUND INFECTION | 2 0.02 99.58 WOUND INFECTION BACTERIAL | 1 0.01 99.59 WOUND INFECTION STAPHYLOCOCCAL | 1 0.01 99.60 WRIST FRACTURE | 2 0.02 99.62 WRONG DRUG ADMINISTERED | 4 0.04 99.66 WRONG TECHNIQUE IN DRUG USAGE PROCESS | 33 0.33 99.99 X-RAY ABNORMAL | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015